Alzheimer disease

G6_ALZHEIMER

Alzheimer's disease: A progressive, neurodegenerative disease characterized by loss of function and death of nerve cells in several areas of the brain leading to loss of cognitive function such as memory and language.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — G30 Hospital discharge: ICD-9 — 3310 Cause of death: ICD-10 — G30 Cause of death: ICD-9 — 3310 2 out of 7 registries used, show all original rules.	14379
4. Check minimum number of events None	14379
5. Include endpoints None	14379
6. Filter based on genotype QC (FinnGen only)	14379

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: G30-G32
Name in latin: Morbus Alzheimer

NAME	G6_ALZHEIMER
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	G30
HD_ICD_9	3310
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	G30
COD_ICD_9	3310
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Alzheimer disease based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	227475	144794	80971
Only index persons	189864	122913	66951
Unadjusted period prevalence (%)
Whole population	3.46	4.15	2.26
Only index persons	3.83	4.52	2.56
Median age at first event (years)
Whole population	82.31	83.07	81.01
Only index persons	82.76	83.50	81.40

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	14379	6758	7621
Unadjusted period prevalence (%)	2.86	2.30	3.36
Median age at first event (years)	80.52	80.57	80.47

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
9844: Matched controls
79845

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

A28

ICPC

Limited function/disability NOS

2.9

323.0

3233

11508

F00.10*G30.1

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

60.2

323.0

2465

440

F00.10

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

32.3

323.0

930

257

P20

ICPC

Memory disturbance

6.5

323.0

4288

8495

N06DA04

ATC

galantamine; oral

19.8

323.0

1265

590

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

6.4

323.0

2581

4185

G30.1

ICD-10 Finland

Alzheimer disease with late onset

123.3

323.0

5812

919

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

273.7

323.0

3421

155

N06DA02

ATC

donepezil; oral

43.5

323.0

4692

1637

N06DA03

ATC

rivastigmine; oral, transdermal

30.4

323.0

2810

1037

G30

ICD-10 Finland

Alzheimer disease

64.9

323.0

855

117

F03

ICD-10 Finland

Unspecified dementia

7.9

323.0

1951

2415

F0019, G301

ICD-10 Finland

+∞

323.0

483

G30.8

ICD-10 Finland

Other Alzheimer disease

54.4

323.0

1700

305

F00.20*G30.8

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

30.5

323.0

1277

388

N06DX01

ATC

memantine; oral

56.7

323.0

5608

1821

P70

ICPC

Dementia

17.4

323.0

1158

606

F00.00*G30.0

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms

209.0

323.0

490

SPAT1053

SPAT

Memory test

3.6

323.0

3770

11844

N05AX08

ATC

risperidone; systemic

10.8

323.0

2669

2648

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

88.4

323.0

4142

651

N05AH04

ATC

quetiapine; oral

4.8

323.0

2140

4378

G30.0

ICD-10 Finland

Alzheimer disease with early onset

442.4

323.0

851

F009, G309

ICD-10 Finland

1455.7

319.0

335

F00.20

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

17.5

292.8

498

242

R41.3

ICD-10 Finland

Other amnesia

6.4

285.5

834

1139

SPAT1245

SPAT

Provision of support and information to patient’s family members

4.2

278.1

1191

2507

R53

ICD-10 Finland

Malaise and fatigue

2.5

267.1

2828

11246

F00.9

ICD-10 Finland

Dementia in Alzheimer disease, unspecified

30.7

261.6

376

103

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.9

238.9

1705

5330

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.1

236.4

3825

18379

SPAT1216

SPAT

Assessment of functional ability

2.3

221.6

2524

10244

N05BA04

ATC

oxazepam; oral

2.2

213.3

2769

11929

F06.7

ICD-10 Finland

Mild cognitive disorder

5.0

208.5

746

1291

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

3.1

202.4

1306

3780

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.0

191.2

3794

19321

SPAT1234

SPAT

Support of social functional capacity

3.4

186.3

1031

2657

WYA20

NOMESCO Finland

Home visit

7.5

181.3

466

523

TAB00

NOMESCO Finland

Lumbar puncture

5.7

178.2

565

846

N06AX11

ATC

mirtazapine; oral

2.0

171.5

3018

14520

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.1

170.5

2553

11503

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.2

163.1

2006

8265

AA1AD

NOMESCO Finland

CT of head and brain

1.9

158.8

3071

15215

F0009, G300

ICD-10 Finland

+∞

155.9

162

F05.1

ICD-10 Finland

Delirium superimposed on dementia

13.0

149.4

285

183

R41.0

ICD-10 Finland

Disorientation, unspecified

3.8

148.8

696

1552

N06AB10

ATC

escitalopram; oral

2.5

147.8

1390

4988

F00.00

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms

70.8

146.2

180

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

3.1

141.0

881

2459

SPAT1254

SPAT

Administration of medicine

2.1

136.3

1959

8554

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.0

135.2

2148

9763

N03AG01

ATC

valproic acid; systemic, rectal

3.8

133.8

628

1402

F0029, G308

ICD-10 Finland

+∞

123.1

128

N02BE01

ATC

paracetamol; systemic, rectal

1.8

119.3

7851

54850

A06AD11

ATC

lactulose; oral

1.9

118.3

2248

10841

N05AH03

ATC

olanzapine; systemic

4.3

116.3

480

951

L28

ICPC

Limited function/disability (L)

1.9

114.3

2172

10454

A04

ICPC

Weakness/tiredness general

2.1

111.1

1571

6747

Z02.4

ICD-10 Finland

Examination for driving licence

0.5

108.1

1227

17205

F0014, G301

ICD-10 Finland

917.9

105.7

112

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.9

103.9

720

2139

N05BA06

ATC

lorazepam; systemic, sublingual

2.8

101.2

720

2173

XA800

NOMESCO Finland

Neuropsychological investigation

4.6

96.4

367

670

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.9

95.0

1695

7910

F00.14

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms of mixed type

49.6

93.4

121

Z75.5

ICD-10 Finland

Holiday relief care

5.7

91.1

285

417

130

Kela drug reimbursment

Malignant tumour

0.3

88.3

206

5285

N05AD01

ATC

haloperidol; systemic

3.1

87.8

523

1398

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

4.7

87.2

322

569

S72.0

ICD-10 Finland

Fracture of neck of femur

2.5

85.1

743

2521

F001, G301

ICD-10 Finland

52.5

85.0

109

N06AB04

ATC

citalopram; systemic

1.8

83.9

1859

9283

U04

ICPC

Incontinence urine

2.5

80.5

679

2257

I67.3

ICD-10 Finland

Progressive vascular leukoencephalopathy

4.8

80.4

290

500

F00.1

ICD-10 Finland

Dementia in Alzheimer disease with late onset

63.1

80.2

100

F00

ICD-10 Finland

Dementia in Alzheimer disease

15.2

80.0

142

N06AX26

ATC

vortioxetine; oral

3.6

79.6

396

923

SPAT1360

SPAT

Extensive global examination

2.2

77.8

918

3609

S01.0

ICD-10 Finland

Open wound of scalp

2.2

74.8

875

3423

NFB20

NOMESCO Finland

Primary partial prosthetic replacement of hip joint using cement, other or unspecified

2.9

73.8

487

1395

R55

ICD-10 Finland

Syncope and collapse

1.8

72.8

1405

6676

N02AA05

ATC

oxycodone; systemic

1.7

71.1

1806

9343

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.8

71.0

1345

6345

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

70.9

1592

7936

SPAT1301

SPAT

No procedures

1.5

70.2

3188

19117

SPAT1101

SPAT

Orthostatic test

2.3

67.6

719

2687

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.3

65.0

649

2351

F21

ICPC

5.2

62.3

208

330

F00.19

ICD-10 Finland

Dementia in Alzheimer's disease with late onset without information about additional symptoms

29.3

59.8

SPAT1246

SPAT

Screening of depression or other psychiatric problem

3.5

57.9

290

680

S06.0

ICD-10 Finland

Concussion

1.9

56.9

919

4078

S70.0

ICD-10 Finland

Contusion of hip

2.5

56.8

486

1623

F05.9

ICD-10 Finland

Delirium, unspecified

3.0

56.1

346

945

I95.1

ICD-10 Finland

Orthostatic hypotension

2.3

55.3

581

2153

SPAT1252

SPAT

Overall medication plan or its review

1.9

54.4

867

3825

SPAT1229

SPAT

Assessment of need for aid

1.8

53.4

1028

4844

SPAT1172

SPAT

Guidance concerning hydration

2.7

53.2

396

1221

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.8

52.5

373

1118

H02AB02

ATC

dexamethasone; systemic

0.4

50.9

221

4367

F0011, G301

ICD-10 Finland

+∞

50.9

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.7

50.7

1304

6701

W19

ICD-10 Finland

Unspecified fall

1.8

50.0

926

4303

G04CA02

ATC

tamsulosin; oral

1.4

48.6

3265

20788

SPAT1304

SPAT

Counselling and guidance related to ageing

1.7

48.3

1076

5298

Z01.9

ICD-10 Finland

Special examination, unspecified

2.2

47.7

525

1988

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

4.0

47.5

206

428

SPAT1251

SPAT

Organisation of medication

2.3

47.4

485

1774

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.8

47.2

975

4691

N05AD03

ATC

melperone; systemic

3.5

47.0

235

551

N02AJ06

ATC

codeine and paracetamol; systemic

0.7

46.8

1383

15923

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.0

46.7

626

2578

3310A

ICD-9 Finland

Other cerebral degenerations, Alzheimer's disease

+∞

46.1

SPAT1153

SPAT

Removal of sutures

0.7

45.7

1709

18847

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.2

44.7

511

1967

N07AA05

ATC

381.6

43.5

E86

ICD-10 Finland

Volume depletion

2.5

43.0

361

1193

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

1.9

43.0

710

3164

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.7

42.8

1106

5671

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

0.6

42.4

1137

13386

R42

ICD-10 Finland

Dizziness and giddiness

1.4

42.1

2246

13613

A29

ICPC

General symptom/complaint other

1.7

42.0

1092

5611

B03BA03

ATC

hydroxocobalamin; parenteral

1.8

41.9

774

3584

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.7

41.8

961

4765

F0024, G308

ICD-10 Finland

+∞

40.3

Z02.7

ICD-10 Finland

Issue of medical certificate

2.0

39.6

567

2394

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.2

39.4

423

1583

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

2.6

38.8

313

1013

C10AA01

ATC

simvastatin; oral

1.3

37.8

5050

35425

G31.8

ICD-10 Finland

Other specified degenerative diseases of nervous system

6.1

37.7

109

146

R41

ICD-10 Finland

Other symptoms and signs involving cognitive functions and awareness

4.6

37.0

137

245

G04CB01

ATC

finasteride; oral (testosterone-5-alpha reductase inhibitors)

1.5

36.7

1765

10438

R33

ICD-10 Finland

Retention of urine

1.6

35.9

1132

6094

N06AB06

ATC

sertraline; oral

1.9

35.8

566

2480

J01DB01

ATC

cefalexin; oral

1.3

35.5

6463

47195

Z29

ICPC

Social problem NOS

3.1

34.2

199

524

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.5

34.1

1237

6880

N40

ICD-10 Finland

Hyperplasia of prostate

1.3

34.1

2943

19251

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.0

33.8

473

1981

N30.0

ICD-10 Finland

Acute cystitis

1.5

33.3

1200

6663

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

1.8

33.3

652

3071

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.4

32.3

1708

10257

SPAT1139

SPAT

Nutrition survey

2.2

32.1

339

1260

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.9

31.8

538

2414

WZC30

NOMESCO Finland

Teaching

0.6

31.6

387

5484

F00.24

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type other additional symptoms of mixed type

28.2

31.4

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

3.0

31.2

188

507

G31.0

ICD-10 Finland

Circumscribed brain atrophy

5.9

30.7

124

A03FA01

ATC

metoclopramide; systemic, rectal

0.7

29.9

893

10371

A04AA02

ATC

granisetron; systemic, transdermal

0.3

29.7

2026

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.4

29.7

1579

9482

SPAT1167

SPAT

Insertion of urinary catheter

1.9

28.9

456

1994

R99

ICD-10 Finland

Other ill-defined and unspecified causes of mortality

2.4

28.9

256

874

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.7

28.7

630

3070

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.2

28.7

308

1154

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

28.5

3072

20621

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

0.3

28.3

1499

WX402

NOMESCO Finland

General anaesthesia

0.6

28.2

387

5331

F00.11

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly paranoidism

21.9

28.0

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

1.9

28.0

443

1941

F01.20

ICD-10 Finland

Subcortical vascular dementia without additional symptoms

3.7

27.8

128

283

F29

ICD-10 Finland

Unspecified nonorganic psychosis

3.4

27.7

142

343

F01.2

ICD-10 Finland

Subcortical vascular dementia

4.5

27.6

102

184

S18

ICPC

Laceration/cut

0.8

27.2

2555

24970

F002, G308

ICD-10 Finland

30.9

27.2

A69

ICPC

General and Unspecified, Other reason for encounter NEC

2.2

27.1

282

1041

R23.8

ICD-10 Finland

Other and unspecified skin changes

0.6

27.0

639

7779

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.4

26.7

244

846

F00.09

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset information on additional symptoms is lacking

40.7

26.5

J01EA01

ATC

trimethoprim; systemic

1.3

26.5

2193

14140

-2

ICPC

4.2

26.3

106

208

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.4

26.3

1415

8495

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.2

26.1

279

1042

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

0.2

25.9

1195

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

0.3

25.4

1474

F01.29

ICD-10 Finland

Subcortical vascular dementia without information on additional symptoms

5.2

25.4

128

A10AE04

ATC

insulin glargine; parenteral

1.6

25.3

802

4312

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.5

25.1

1106

6385

SPAT1276

SPAT

Outlining of treatment with patient or their family members

2.2

25.1

258

949

F0012, G301

ICD-10 Finland

+∞

25.0

Z51.88

ICD-10 Finland

Other specified medical care

2.5

24.6

205

678

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.6

24.5

743

3945

S72.1

ICD-10 Finland

Pertrochanteric fracture

2.0

24.4

321

1313

F00.13

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly depression

30.7

24.3

J01CA08

ATC

pivmecillinam; oral

1.3

24.3

2558

17030

AA5DR

NOMESCO Finland

Brain metabolism PET with CT

25.9

24.0

L82

ICD-10 Finland

Seborrhoeic keratosis

0.7

23.6

664

7823

N28

ICPC

Limited function/disability (N)

2.6

23.5

175

544

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

1.8

23.4

461

2176

R1250

NOMESCO Finland

Evaluation of functional capability

2.7

22.7

163

497

Z28

ICPC

Limited function/disability (Z)

4.4

22.6

161

G04BD08

ATC

solifenacin; oral

1.6

22.1

697

3737

F0021, G308

ICD-10 Finland

+∞

22.1

AXX01

SPAT

2.6

21.9

171

545

E000001

ATC

1.4

21.5

1459

9084

F00.2

ICD-10 Finland

Dementia in Alzheimer disease, atypical or mixed type

33.7

21.3

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.0

21.1

292

1218

Z13.3

ICD-10 Finland

Special screening examination for mental and behavioural disorders

12.1

21.1

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

0.8

21.1

1650

16610

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.5

20.8

899

5163

J01MA02

ATC

ciprofloxacin; systemic

1.2

20.8

3511

24661

4912B

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]

0.2

20.7

894

F00.01

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms, mainly paranoidism

52.8

20.7

RD211

NOMESCO Finland

0.4

20.7

1479

8070/3-C34.9

ICD-O-3

Squamous cell carcinoma, NOS, of lung, NOS

0.2

20.7

795

SPAT1050

SPAT

Extensive neurological examination

2.2

20.5

227

864

SAB01

NOMESCO Finland

Restricted oral and dental health check by dental hygienist or dental assistant

1.7

20.3

439

2131

N07AA06

ATC

+∞

20.2

F0013, G301

ICD-10 Finland

+∞

20.2

F0022, G308

ICD-10 Finland

+∞

20.2

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

0.4

19.8

1857

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.6

19.8

585

3086

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

0.7

19.7

1041

11068

F00.12

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset, other additional symptoms, mainly hallucinations

17.4

19.6

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.5

19.4

817

4663

SPAT1307

SPAT

Psychosocial counselling and guidance

2.2

19.2

194

709

F0004, G300

ICD-10 Finland

+∞

19.2

F0023, G308

ICD-10 Finland

+∞

19.2

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

2.4

19.1

169

579

F22.0

ICD-10 Finland

Delusional disorder

2.8

18.8

127

374

R11

ICD-10 Finland

Nausea and vomiting

1.5

18.7

622

3377

N29

ICPC

Neurological sympt/complt other

2.3

18.6

176

623

WX212

NOMESCO Finland

Femoral plexus blockade

2.1

18.6

207

793

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

0.7

18.4

565

6564

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.2

18.3

3062

21402

UGC12

NOMESCO Finland

Flexible bronchoscopy

0.6

18.2

414

5096

F009, G301

ICD-10 Finland

+∞

18.2

F0024, G301

ICD-10 Finland

+∞

18.2

E0000UV

ATC

1.2

18.2

2804

19421

N30.9

ICD-10 Finland

Cystitis, unspecified

1.6

18.2

469

2392

XX3DW

NOMESCO Finland

Time consuming IT work

0.6

18.1

348

4438

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

4.3

17.9

128

N06AX16

ATC

venlafaxine; oral

1.6

17.9

543

2883

SPAT1284

SPAT

Extensive health certificate

2.1

17.9

206

798

A04AA01

ATC

ondansetron; systemic, rectal

0.5

17.8

156

2432

F01.9

ICD-10 Finland

Vascular dementia, unspecified

2.0

17.6

235

967

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.4

17.6

755

4325

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

0.5

17.5

194

2828

4289X

ICD-9 Finland

Heart failure, unspecified

0.1

17.5

438

SPAT1263

SPAT

Sampling

1.2

17.4

3334

23606

L01BC06

ATC

capecitabine; oral

0.4

17.3

1322

AAA20

NOMESCO Finland

Insertion of intraventricular pressure monitoring device

6.5

17.1

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

1.4

17.1

1099

6766

SPAT1058

SPAT

PEF monitoring instruction

0.6

17.0

266

3553

F00.04

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms of mixed type

81.3

16.9

SPAT1279

SPAT

Preparation of immediate hospitalisation

2.4

16.9

148

505

NFJ54

NOMESCO Finland

Internal fixation of fracture of upper femur with intramedullary nail

2.1

16.9

204

811

JN4AD

NOMESCO Finland

Body CT examination

0.6

16.8

280

3686

2900A

ICD-9 Finland

Senile and presenile organic psychotic conditions, Senile dementia, uncomplicated

5.4

16.8

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.2

16.6

2610

18076

K59.0

ICD-10 Finland

Constipation

1.5

16.5

551

2992

SDA04

NOMESCO Finland

Very demanding parodonthologic therapy

0.7

16.5

612

6889

N05AB03

ATC

perphenazine; systemic, rectal

2.0

16.5

205

822

Z51.5

ICD-10 Finland

Palliative care

1.5

16.5

636

3566

S00.0

ICD-10 Finland

Superficial injury of scalp

2.1

16.5

184

705

SAD02

NOMESCO Finland

Assessment of need for oral health care, extensive

2.3

16.4

159

572

P05

ICPC

Senility, feeling/behaving old

3.3

16.4

215

C04AE01

ATC

ergoloid mesylates; systemic

2.7

16.3

116

354

H02AA02

ATC

fludrocortisone; oral

2.7

16.3

115

348

A01

ICPC

Pain general/multiple sites

1.5

16.3

590

3263

F00.23

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type of other additional symptoms, mainly depression

42.6

16.2

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.4

16.2

883

5287

WF049

NOMESCO Finland

Radiotherapy of metastasis

0.4

16.2

1410

LAITO

NOMESCO Finland

13.1

16.1

H02AB06

ATC

prednisolone; systemic

0.8

15.9

3143

28850

U13

ICPC

Bladder symptom/complaint other

1.9

15.8

253

1118

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

2.0

15.8

207

850

G91.0

ICD-10 Finland

Communicating hydrocephalus

4.0

15.8

133

C03CA01

ATC

furosemide; systemic

1.2

15.8

3957

28681

G91.9

ICD-10 Finland

Hydrocephalus, unspecified

4.1

15.7

122

N06AX21

ATC

duloxetine; oral

1.5

15.7

538

2943

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.3

15.6

1288

8234

L08

ICPC

Shoulder symptom/complaint

0.7

15.6

803

8589

Y94.1

ICD-10 Finland

Accident in connection with service housing

10.5

15.5

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

0.5

15.5

106

1780

G31.9

ICD-10 Finland

Degenerative disease of nervous system, unspecified

4.9

15.5

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

0.4

15.3

1403

N03AX14

ATC

levetiracetam; systemic

2.1

15.3

183

726

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.2

15.2

2530

17595

F05.0

ICD-10 Finland

Delirium not superimposed on dementia, so described

4.3

15.2

111

SPAT1262

SPAT

Handing over of treatment supplies

1.3

15.1

1553

10218

WF002

NOMESCO Finland

Radical radiotherapy

0.5

15.1

148

2229

L15

ICPC

Knee symptom/complaint

0.8

15.0

927

9669

Z60.8

ICD-10 Finland

Other problems related to social environment

5.0

14.9

W06

ICD-10 Finland

Fall involving bed

2.7

14.9

101

301

Y94.0

ICD-10 Finland

Accident at home

2.1

14.8

172

673

R03AC02

ATC

salbutamol; inhalant

0.8

14.7

2959

27172

M01AH05

ATC

etoricoxib; oral

0.8

14.7

2699

24989

S01

ICD-10 Finland

Open wound of head

2.5

14.7

116

376

H25.1

ICD-10 Finland

Senile nuclear cataract

1.2

14.6

3453

24839

S15

ICPC

Foreign body in skin

0.6

14.6

176

2504

F009, F03

ICD-10 Finland

12.2

14.6

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.3

14.4

132

461

R00.1

ICD-10 Finland

Bradycardia, unspecified

1.6

14.4

379

1945

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.3

14.4

938

5783

F000, G300

ICD-10 Finland

+∞

14.4

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.4

14.4

624

3583

P29

ICPC

Psychological sympt/compl other

2.0

14.4

178

715

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

0.7

14.4

526

5932

F00.0

ICD-10 Finland

Dementia in Alzheimer disease with early onset

48.7

14.3

K08.3

ICD-10 Finland

Retained dental root

1.5

14.2

485

2648

F02.09*G31.0

ICD-10 Finland

Dementia in Pick's disease without information on additional symptoms

9.0

14.0

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

1.9

13.9

206

887

G46.8*I67.9

ICD-10 Finland

Other vascular syndromes of brain in cerebrovascular diseases

5.8

13.9

N05CD07

ATC

temazepam; oral

1.3

13.9

1374

8987

PJA12

NOMESCO Finland

Sentinel node biopsy

0.6

13.9

179

2507

DFF00

NOMESCO Finland

Pure tone audiometry

0.7

13.8

385

4559

HMAK

NOMESCO Finland

0.6

13.8

289

3620

Z51.0

ICD-10 Finland

Radiotherapy session

0.2

13.8

509

G04CA01

ATC

alfuzosin; oral

1.3

13.8

1204

7748

XF606

NOMESCO Finland

Ortostatic test

2.8

13.8

263

S28

ICPC

Limited function/disability (S)

3.3

13.7

168

G04CB02

ATC

dutasteride; oral

1.4

13.7

780

4703

A10AE05

ATC

insulin detemir; parenteral

1.6

13.7

397

2086

A06AC01

ATC

ispaghula (psylla seeds); oral

1.2

13.7

2041

14010

G31.1

ICD-10 Finland

Senile degeneration of brain, not elsewhere classified

6.5

13.6

N17

ICPC

Vertigo/dizziness

1.3

13.6

964

6017

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

0.8

13.4

1524

14810

F0019, G309

ICD-10 Finland

+∞

13.4

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

0.3

13.4

798

J96.1

ICD-10 Finland

Chronic respiratory failure

0.5

13.4

1430

R32

ICD-10 Finland

Unspecified urinary incontinence

1.8

13.3

249

1160

SPAT1111

SPAT

Planning of analgesia

2.5

13.2

108

359

R06.0

ICD-10 Finland

Dyspnoea

0.8

13.2

1669

16043

AAD10

NOMESCO Finland

Evacuation of chronic subdural haematoma

2.0

13.1

177

735

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

0.6

13.1

217

2861

S01.1

ICD-10 Finland

Open wound of eyelid and periocular area

1.9

13.0

181

763

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

2.8

13.0

248

P04

ICPC

Feeling/behaving irritable/angry

6.6

13.0

F00.21

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type of other additional symptoms, mainly paranoidism

17.1

13.0

A78

ICPC

Infectious disease other/NOS

2.7

13.0

268

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

0.6

13.0

219

2872

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

0.5

13.0

104

1658

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

0.4

12.9

917

SPAT1125

SPAT

Stoma care and guidance

1.9

12.8

181

768

R50.9

ICD-10 Finland

Fever, unspecified

1.3

12.8

1052

6709

F00, F03

ICD-10 Finland

8.1

12.8

P28

ICPC

Limited function/disability (P)

3.7

12.7

123

N99

ICPC

Neurological disease other

2.5

12.7

316

N05CF01

ATC

zopiclone; oral

1.2

12.6

2995

21483

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

2.2

12.5

132

497

N02AX02

ATC

tramadol; systemic, rectal

0.8

12.4

2774

25344

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.4

12.4

514

2925

S01.8

ICD-10 Finland

Open wound of other parts of head

2.4

12.4

110

380

F05.8

ICD-10 Finland

Other delirium

2.6

12.4

276

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

2.8

12.4

224

X59

ICD-10 Finland

Exposure to unspecified factor

1.3

12.3

1132

7330

EBA15

NOMESCO Finland

Extraction of large number of teeth

1.7

12.3

267

1302

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.5

12.1

419

2297

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

0.7

12.1

418

4760

WW500

NOMESCO Finland

Blood transfusion

0.5

12.0

121

1806

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

0.7

12.0

422

4796

S82

ICPC

Naevus/mole

0.7

12.0

434

4907

M70.6

ICD-10 Finland

Trochanteric bursitis

0.7

11.9

509

5607

KMAK

NOMESCO Finland

1.2

11.9

2786

19929

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

0.8

11.9

1230

12087

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

0.3

11.8

570

CA1TM

NOMESCO Finland

Calculation of intraocular lens power

0.4

11.5

910

N27

ICPC

Fear of neurological disease other

2.1

11.5

128

494

F0001, G300

ICD-10 Finland

+∞

11.5

N05AH02

ATC

clozapine; systemic

3.7

11.4

110

F00.29

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without information on additional symptoms

13.5

11.4

F00.22

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type other additional symptoms, mainly hallucinations

15.4

11.4

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

0.3

11.4

545

I95.9

ICD-10 Finland

Hypotension, unspecified

2.0

11.4

147

604

T05

ICPC

Feeding problem of adult

3.5

11.4

123

WX111

NOMESCO Finland

Local infiltration anesthesia

0.5

11.4

1214

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

0.2

11.3

483

115

Kela drug reimbursment

Breast cancer

0.6

11.2

211

2702

L75

ICPC

Fracture: femur

2.0

11.2

141

571

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

0.6

11.2

131

1877

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

0.6

11.2

145

2025

SPAT1014

SPAT

Treatment of eyes

1.9

11.2

170

743

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.5

11.1

274

N18

ICPC

Paralysis/weakness

1.8

11.1

179

798

G04BD07

ATC

tolterodine; oral

1.4

11.1

515

2998

S42.2

ICD-10 Finland

Fracture of upper end of humerus

1.5

11.1

363

1967

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

0.4

11.1

1017

L57.0

ICD-10 Finland

Actinic keratosis

0.8

11.1

705

7337

S01BC05

ATC

ketorolac; ophthalmic

1.4

11.1

484

2785

JN4BD

NOMESCO Finland

Extensive body CT

0.7

11.1

553

5948

CBB11

NOMESCO Finland

Resection of lax skin in upper eyelid

0.4

11.0

818

Z75.0

ICD-10 Finland

Medical services not available in home

4.3

11.0

R29.6

ICD-10 Finland

Tendency to fall, not elsewhere classified

3.3

11.0

135

D12

ICPC

Constipation

1.6

10.9

305

1590

AA1AD

SPAT

5.4

10.9

ZX120

NOMESCO Finland

Intravenous

0.7

10.8

399

4500

S22.3

ICD-10 Finland

Fracture of rib

1.4

10.8

486

2810

WF003

NOMESCO Finland

Adjuvant radiotherapy

0.5

10.7

1201

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

1.6

10.7

303

1588

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

3.8

10.7

A10BB12

ATC

glimepiride; oral

1.3

10.7

839

5315

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

0.2

10.7

420

R01AD12

ATC

fluticasone furoate; nasal

0.8

10.7

785

8027

L03AA13

ATC

pegfilgrastim; parenteral

0.4

10.6

1059

J01.0

ICD-10 Finland

Acute maxillary sinusitis

0.7

10.6

582

6176

F0021, G301

ICD-10 Finland

+∞

10.6

F009, G308

ICD-10 Finland

+∞

10.6

F0009, G309

ICD-10 Finland

+∞

10.6

A10AD05

ATC

insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

1.7

10.5

220

1063

F10.73

ICD-10 Finland

Residual or late-onset psychosis caused by alcohol dementia

4.9

10.5

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

3.3

10.5

127

4148X

ICD-9 Finland

Other forms of chronic ischaemic heart disease, Other specified forms of chronic ischaemic heart disease[MORBUS CORDIS ISCHAEMICUS ALIA,MÄÄRITTELEMÄT]

0.3

10.5

646

L90

ICPC

Osteoarthrosis of knee

0.7

10.5

241

2959

K86

ICPC

Hypertension uncomplicated

0.8

10.5

674

7006

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

0.4

10.5

862

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

2.0

10.4

129

523

R2110

NOMESCO Finland

Giving the first information

1.5

10.4

362

1990

SPAT1043

SPAT

Audiometry

0.8

10.4

648

6765

N39.9

ICD-10 Finland

Disorder of urinary system, unspecified

2.0

10.4

139

580

A05

ICPC

Feeling ill

1.6

10.4

258

1309

K80

ICPC

Cardiac arrhythmia NOS

0.7

10.4

294

3466

NF1AA

NOMESCO Finland

Hip X-ray examination

1.3

10.3

777

4896

L01

ICPC

Neck symptom/complaint

0.7

10.3

472

5142

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

3.9

10.2

D19

ICPC

Teeth/gum symptom/complaint

0.8

10.2

791

8041

R03BA08

ATC

ciclesonide; inhalant

0.6

10.2

202

2558

KED22

NOMESCO Finland

Transurethral resection of prostate

1.3

10.2

797

5046

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

1.8

10.2

182

841

A10BK03

ATC

empagliflozin; oral

0.6

10.2

168

2213

TPX10

NOMESCO Finland

Implantation of vascular injection port

0.4

10.2

972

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

0.8

10.1

2200

20219

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.5

10.1

330

1792

A23

ICPC

Risk factor NOS

1.6

10.0

278

1449

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.7

10.0

225

1110

XCH00

NOMESCO Finland

Eye pressure measurement

0.6

10.0

145

1966

C03DA01

ATC

spironolactone; oral

0.8

10.0

711

7299

8041/3-C34.9

ICD-O-3

Small cell carcinoma, NOS, of lung, NOS

0.2

10.0

418

AA1AA

NOMESCO Finland

Head X-ray examination

2.4

10.0

271

F09

ICD-10 Finland

Unspecified organic or symptomatic mental disorder

7.2

10.0

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

0.7

9.9

280

3305

G72.8

ICD-10 Finland

Other specified myopathies

1.9

9.9

147

636

L03AA02

ATC

filgrastim; parenteral

0.4

9.9

867

R45.5

ICD-10 Finland

Hostility

12.2

9.9

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

4.0

9.9

Z11

ICPC

Compliance/being ill problem

2.9

9.9

173

R40.2

ICD-10 Finland

Coma, unspecified

2.3

9.8

308

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

0.7

9.8

265

3150

C10AA07

ATC

rosuvastatin; oral

0.8

9.8

1311

12573

L03

ICPC

Low back symptom/complaint

0.8

9.8

1089

10633

K59.09

ICD-10 Finland

Constipation, unspecified

1.4

9.8

537

3222

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

0.5

9.7

1060

EB1AA

NOMESCO Finland

Tooth X-ray examination

0.9

9.7

2447

22251

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.5

9.7

320

1738

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

1.7

9.7

213

1047

F06.9

ICD-10 Finland

Unspecified mental disorder due to brain damage and dysfunction and to physical disease

4.1

9.5

8000/3-C34.9

ICD-O-3

Neoplasm, malignant of lung, NOS

0.5

9.5

997

A04AA55

ATC

palonosetron, combinations; systemic

0.2

9.5

418

U28

ICPC

Limited function/disability (U)

2.0

9.5

111

442

Z20.8

ICD-10 Finland

Contact with and exposure to other communicable diseases

1.8

9.4

171

793

EBA30

NOMESCO Finland

Excision of root of tooth

1.5

9.4

369

2083

HA1RA

SPAT

0.2

9.3

387

N95.1

ICD-10 Finland

Menopausal and female climacteric states

0.5

9.3

1014

SPAT1098

SPAT

Exercise ECG

0.4

9.3

738

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

0.6

9.3

121

1686

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

0.8

9.3

942

9295

65000

ICD-8 Finland

Delivery without mention of complication, Occipital presentation

0.8

9.3

775

7808

S32.8

ICD-10 Finland

Fracture of other and unspecified parts of lumbar spine and pelvis

2.1

9.3

100

384

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.2

9.3

3389

25002

JAB30

NOMESCO Finland

Repair of inguinal hernia using prosthetic material

1.3

9.2

978

6439

R1250

SPAT

3.0

9.2

139

SPAT1157

SPAT

Guidance concerning treatment of mouth and mucous membranes

2.1

9.2

106

418

N05AX12

ATC

aripiprazole; systemic

2.6

9.1

216

LAF11

NOMESCO Finland

Laparoscopic bilateral salpingo-oophorectomy

0.5

9.1

1334

SPAT1285

SPAT

Provision of consultation response

1.4

9.1

403

2330

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

0.7

9.1

290

3344

G40

ICD-10 Finland

Epilepsy

3.1

9.0

136

R44.3

ICD-10 Finland

Hallucinations, unspecified

3.1

9.0

136

M04AA01

ATC

allopurinol; systemic

0.8

9.0

1031

10049

WX199

NOMESCO Finland

Other local analgesia

0.5

9.0

1200

Z43.5

ICD-10 Finland

Attention to cystostomy

2.4

9.0

250

D07AA02

ATC

hydrocortisone; topical

1.3

9.0

816

5273

F22.9

ICD-10 Finland

Persistent delusional disorder, unspecified

3.3

9.0

108

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.8

9.0

161

N05AA02

ATC

levomepromazine; systemic

1.6

8.9

249

1302

S42.0

ICD-10 Finland

Fracture of clavicle

1.8

8.9

156

717

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

1.2

8.9

1223

8287

S06.3

ICD-10 Finland

Focal brain injury

2.0

8.9

113

466

SPAT1042

SPAT

Guidance concerning balance maintenance

2.6

8.9

202

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

0.3

8.9

490

SPAT1236

SPAT

Informing family of child’s disability

1.7

8.8

164

768

T03

ICPC

Loss of appetite

3.9

8.8

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

0.5

8.8

991

R45.1

ICD-10 Finland

Restlessness and agitation

4.9

8.8

F00.02

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms, mainly illusions

44.6

8.8

SPAT1104

SPAT

Monitoring of emergency patient

1.4

8.7

516

3134

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.2

8.7

1257

8561

T36

ICD-10 Finland

Poisoning by systemic antibiotics

1.8

8.7

143

646

I48.1

ICD-10 Finland

Persistent atrial fibrillation

0.6

8.7

106

1496

ZXA00

NOMESCO Finland

Right side

1.2

8.7

2346

16902

IAB14

NOMESCO Finland

Geriatric psychiatry consultation

4.3

8.6

R63.4

ICD-10 Finland

Abnormal weight loss

1.5

8.6

282

1534

M75.1

ICD-10 Finland

Rotator cuff syndrome

0.8

8.6

1082

10449

C10AX09

ATC

ezetimibe; oral

0.8

8.6

480

5084

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

0.8

8.6

1214

11596

DAX08

NOMESCO Finland

Fitting of hearing aid

0.7

8.6

227

2707

C10AA02

ATC

lovastatin; oral

1.4

8.6

499

3024

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

1.5

8.6

266

1430

D51.9

ICD-10 Finland

Vitamin B12deficiency anaemia, unspecified

1.9

8.5

122

525

NFB10

NOMESCO Finland

Primary partial prosthetic replacement of hip joint not using cement, other or unspecified

2.8

8.5

153

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.5

8.4

290

1594

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

0.6

8.4

174

2179

R21

ICPC

Throat symptom/complaint

0.7

8.3

444

4731

K22

ICPC

Risk factor cardiovascular disease

0.7

8.2

221

2631

R05

ICPC

Cough

0.8

8.2

1020

9865

Z73.6

ICD-10 Finland

Limitation of activities due to disability

2.2

8.2

284

T08

ICPC

Weight loss

1.9

8.2

112

474

SPAT1138

SPAT

Guidance concerning bowel function

1.8

8.2

127

560

180

Kela drug reimbursment

Interferon alfa

0.0

8.2

168

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.4

8.2

382

2230

I69.0

ICD-10 Finland

Sequelae of subarachnoid haemorrhage

2.2

8.1

289

I61.1

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, cortical

2.2

8.1

289

C09AA05

ATC

ramipril; oral

1.2

8.1

2522

18347

HA1AA

NOMESCO Finland

X-ray mammography

0.7

8.1

193

2349

CHD05

NOMESCO Finland

Selective lasertrabeculoplasty

0.6

8.1

103

1439

G20

ICD-10 Finland

Parkinson disease

1.4

8.1

330

1880

A69.2

ICD-10 Finland

Lyme disease

0.6

8.0

125

1666

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

0.8

8.0

502

5240

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.3

8.0

599

3769

SDA02

NOMESCO Finland

Parodonthologic therapy

0.8

8.0

1283

12127

K90

ICPC

Stroke/cerebrovascular accident

1.5

8.0

276

1519

D25.9

ICD-10 Finland

Leiomyoma of uterus, unspecified

0.6

8.0

111

1518

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.5

8.0

302

1694

R26

ICD-10 Finland

Abnormalities of gait and mobility

3.7

8.0

Z03

ICPC

Housing/neighbourhood problem

2.7

8.0

163

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

1.7

8.0

158

757

WX404

NOMESCO Finland

Intravenous generell anesthesy

0.8

8.0

833

8194

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.3

8.0

685

4395

R54

ICD-10 Finland

Senility

2.5

7.9

199

F32

ICD-10 Finland

Depressive episode

1.6

7.9

181

901

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.7

7.9

165

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

0.8

7.9

1197

11367

R74

ICPC

Upper respiratory infection acute

0.8

7.9

681

6839

F01.19

ICD-10 Finland

Multi-infarct dementia without information on additional symptoms

3.0

7.9

123

F00.03

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenil onset other additional symptoms, mainly depression

40.6

7.9

E53.8

ICD-10 Finland

Deficiency of other specified B group vitamins

2.4

7.9

207

S00.1

ICD-10 Finland

Contusion of eyelid and periocular area

1.9

7.9

113

489

S12

ICPC

Insect bite/sting

0.7

7.8

312

3469

SPAT1244

SPAT

Occupational therapy

2.1

7.8

340

F10.0

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Acute intoxication

0.3

7.8

435

XA400

NOMESCO Finland

EEG

2.7

7.8

153

TK800

NOMESCO Finland

Hemodialysis

0.4

7.8

760

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

1.4

7.8

445

2688

Z60.9

ICD-10 Finland

Problem related to social environment, unspecified

3.3

7.8

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.3

7.8

815

5360

A12AA04

ATC

calcium carbonate; oral

0.4

7.7

637

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

0.4

7.7

637

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

0.2

7.7

344

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

0.6

7.7

165

2050

N03AF02

ATC

oxcarbazepine; oral

1.6

7.7

179

897

L13

ICPC

Hip symptom/complaint

0.8

7.7

880

8581

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

3.0

7.7

121

R31

ICD-10 Finland

Unspecified haematuria

1.2

7.7

1057

7165

K91

ICPC

Cerebrovascular disease

1.8

7.6

132

609

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.4

7.6

355

2073

N95.2

ICD-10 Finland

Postmenopausal atrophic vaginitis

0.6

7.6

115

1538

L02BG04

ATC

letrozole; oral

0.6

7.5

139

1779

D82

ICPC

Teeth/gum disease

0.8

7.5

1157

10972

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.2

7.5

2223

16103

T90.5

ICD-10 Finland

Sequelae of intracranial injury

2.3

7.5

229

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

0.6

7.4

147

1857

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

0.7

7.4

218

2552

R03BB01

ATC

ipratropium bromide; inhalant

0.7

7.4

319

3505

N81.1

ICD-10 Finland

Cystocele

0.7

7.4

207

2443

SPAT1059

SPAT

Spirometry at the office

0.7

7.4

185

2226

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

0.7

7.4

211

2478

M05BA02

ATC

clodronic acid; systemic

0.2

7.4

274

G04BD10

ATC

darifenacin; oral

2.3

7.4

241

Z49.1

ICD-10 Finland

Extracorporeal dialysis

0.3

7.4

472

C01DA14

ATC

isosorbide mononitrate; oral

1.2

7.4

2247

16307

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

0.3

7.3

405

I61.9

ICD-10 Finland

Intracerebral haemorrhage, unspecified

1.7

7.3

160

788

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

0.9

7.3

2362

21188

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

0.4

7.3

661

WX302

NOMESCO Finland

Thoracal epidural anesthesy

0.7

7.3

162

1994

F01

ICD-10 Finland

Vascular dementia

2.7

7.3

153

A96

ICPC

Death

2.4

7.3

205

HAB99

NOMESCO Finland

Other partial excision of mammary gland

0.4

7.2

583

A01AB09

ATC

miconazole; local oral

1.3

7.2

686

4457

SDA01

NOMESCO Finland

Simple parodonthologic therapy

0.8

7.2

860

8353

G25.9

ICD-10 Finland

Extrapyramidal and movement disorder, unspecified

2.0

7.2

374

R35

ICD-10 Finland

Polyuria

1.3

7.2

523

3281

G04BX04

ATC

1.5

7.2

241

1319

B01AC24

ATC

ticagrelor; oral

0.6

7.2

1263

S21

ICPC

Skin texture symptom/complaint

0.8

7.2

597

6017

TGC00

NOMESCO Finland

Bronchial lavation

0.5

7.1

970

B01AA03

ATC

warfarin; systemic

1.1

7.1

2601

19114

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

0.5

7.1

824

R44.1

ICD-10 Finland

Visual hallucinations

2.6

7.1

152

N04AA02

ATC

biperiden; systemic

1.9

7.1

100

429

NFJ52

NOMESCO Finland

Internal fixation of fracture of upper femur with screws and sideplate

1.9

7.1

418

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.3

7.0

642

4152

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

0.7

7.0

327

3552

UKC02

NOMESCO Finland

Cystoscopy

1.2

7.0

1717

12253

XJH00

NOMESCO Finland

Transanal ultrasonography

1.2

7.0

749

4938

LCA06

NOMESCO Finland

Biopsy of endometrium

0.7

7.0

226

2599

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

0.6

7.0

1159

E87.6

ICD-10 Finland

Hypokalaemia

1.5

7.0

218

1178

L04AX01

ATC

azathioprine; systemic

0.6

7.0

1222

S32.4

ICD-10 Finland

Fracture of acetabulum

2.2

7.0

240

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.2

7.0

752

4962

I27.9

ICD-10 Finland

Pulmonary heart disease, unspecified

0.2

7.0

277

N05AL01

ATC

sulpiride; systemic

1.9

7.0

423

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

0.5

7.0

855

P99

ICPC

Psychological disorders other

2.2

7.0

268

F99

ICD-10 Finland

Mental disorder, not otherwise specified

2.5

7.0

175

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.5

7.0

251

1396

S20.2

ICD-10 Finland

Contusion of thorax

1.4

6.9

306

1772

C34.16

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary microcellular carcinoma

0.1

6.9

209

SPAT1281

SPAT

Other administrative function

1.3

6.9

513

3226

S01.41

ICD-10 Finland

Open wound in the temple-jaw region

2.2

6.9

252

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

0.7

6.9

312

3404

G04BD11

ATC

fesoterodine; oral

1.4

6.9

269

1520

WVA30

SPAT

0.5

6.9

782

IBZ07

NOMESCO Finland

Neurological assessment in psychiatry

6.6

6.8

T68

ICD-10 Finland

Hypothermia

2.7

6.8

131

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

0.7

6.8

177

2117

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

3.5

6.8

G47.3

ICD-10 Finland

Sleep apnoea

0.8

6.8

778

7585

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.2

6.8

1902

13710

G04BD12

ATC

mirabegron; oral

1.2

6.8

887

5980

B01AC07

ATC

dipyridamole; systemic

1.3

6.7

699

4591

Z74.1

ICD-10 Finland

Need for assistance with personal care

8.7

6.7

R03DA04

ATC

theophylline; systemic, rectal

0.8

6.7

441

4572

F0010, G308

ICD-10 Finland

+∞

6.7

F0022, G301

ICD-10 Finland

+∞

6.7

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

0.9

6.7

1763

16047

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

0.4

6.7

635

I64

ICD-10 Finland

Stroke, not specified as haemorrhage or infarction

2.1

6.6

292

TQW40

SPAT

0.5

6.6

916

G04CA52

ATC

tamsulosin and dutasteride; systemic

1.2

6.6

954

6494

N05BE01

ATC

buspirone; oral

1.7

6.6

126

598

A04AD12

ATC

aprepitant; systemic

0.3

6.6

343

H01

ICPC

Ear pain/earache

0.7

6.6

278

3064

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.3

6.6

416

2559

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

0.4

6.6

513

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

0.6

6.6

1032

128

Kela drug reimbursment

Cancers of female genital organs

0.4

6.6

461

C34.19

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology

0.3

6.6

356

207

Kela drug reimbursment

Chronic arrhythmias

0.9

6.6

1293

12025

SPAT1109

SPAT

Analgesia with portable analgesic pump

2.4

6.6

189

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

0.6

6.5

137

1705

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

0.8

6.5

469

4810

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

1.6

6.5

165

847

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.6

6.5

168

866

R03AK07

ATC

formoterol and budesonide; inhalant

0.8

6.5

715

7000

G91.1

ICD-10 Finland

Obstructive hydrocephalus

3.2

6.5

S06.2

ICD-10 Finland

Diffuse brain injury

2.1

6.5

271

A11CC03

ATC

alfacalcidol; systemic

0.5

6.5

976

HAB40

NOMESCO Finland

Wedge excision of mammary gland

0.6

6.5

122

1552

201

Kela drug reimbursment

Chronic cardiac insufficiency

0.8

6.5

400

4179

T93

ICPC

Lipid disorder

0.7

6.5

193

2248

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

0.8

6.5

644

6367

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.5

6.4

239

1340

G21.0

ICD-10 Finland

Malignant neuroleptic syndrome

7.2

6.4

SGC00

NOMESCO Finland

Local medication of root channels of tooth

0.7

6.4

192

2234

Z01.2

ICD-10 Finland

Dental examination

0.9

6.4

1605

14668

K03.64

ICD-10 Finland

Dental calculus supragingival

0.8

6.4

824

7946

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.8

6.4

443

F01.10

ICD-10 Finland

Multi-infarct dementia without additional symptoms

2.7

6.4

122

HA1RA

NOMESCO Finland

Combined assessment of mammary gland (mammography and ultrasound)

0.3

6.4

325

F16

ICPC

Eyelid symptom/complaint

0.6

6.4

128

1608

P15

ICPC

Chronic alcohol abuse

2.0

6.4

330

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

0.6

6.3

1094

GD1AA

SPAT

0.5

6.3

903

N81.6

ICD-10 Finland

Rectocele

0.7

6.3

193

2237

G21.1

ICD-10 Finland

Other drug-induced secondary parkinsonism

3.7

6.3

I50.9

ICD-10 Finland

Heart failure, unspecified

1.2

6.3

1841

13302

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.2

6.3

1177

8209

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

0.7

6.3

151

1830

H04AA01

ATC

glucagon; nasal, parenteral

2.1

6.3

281

4402A

ICD-9 Finland

Atherosclerosis, Of native arteries of the extremities

0.6

6.3

1009

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

1.6

6.3

167

871

EBA00

NOMESCO Finland

Extraction of tooth

1.1

6.3

1885

13648

M19.0

ICD-10 Finland

Primary arthrosis of other joints

0.8

6.3

348

3683

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

0.3

6.3

376

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.8

6.2

106

I95.0

ICD-10 Finland

Idiopathic hypotension

3.4

6.2

F06.0

ICD-10 Finland

Organic hallucinosis

3.4

6.2

S72.2

ICD-10 Finland

Subtrochanteric fracture

1.9

6.2

370

N84.0

ICD-10 Finland

Polyp of corpus uteri

0.7

6.2

168

1989

D17

ICPC

Incontinence of bowel

2.0

6.2

284

A77

ICPC

Viral disease other/NOS

0.4

6.2

450

NFB40

NOMESCO Finland

Primary total prosthetic replacement of hip joint using hybrid technique

0.7

6.2

174

2047

I67.9

ICD-10 Finland

Cerebrovascular disease, unspecified

1.8

6.2

421

R12

ICD-10 Finland

Heartburn

0.7

6.2

200

2298

I21.99

ICD-10 Finland

Myocardial infarction (acute) UNS unspecified coronary artery status

1.4

6.2

326

1950

Z02.8

ICD-10 Finland

Other examinations for administrative purposes

3.0

6.2

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

0.7

6.2

245

2719

ACC51

NOMESCO Finland

Release of median nerve

0.7

6.2

195

2247

Z46.9

ICD-10 Finland

Fitting and adjustment of unspecified device

1.7

6.2

111

519

B01AF01

ATC

rivaroxaban; oral

0.8

6.1

705

6874

G04BD04

ATC

oxybutynin; oral, transdermal

1.3

6.1

517

3315

F0289, G318

ICD-10 Finland

32.4

6.1

D70.82

ICD-10 Finland

Drug-induced neutropenia

0.4

6.1

421

Z08

ICPC

Social welfare problem

2.1

6.1

252

ZXC96

NOMESCO Finland

Robot assisted procedure

0.5

6.1

648

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

0.7

6.1

138

1687

L01CA04

ATC

vinorelbine; systemic

0.3

6.1

285

Z51.4

ICD-10 Finland

Preparatory care for subsequent treatment, not elsewhere classified

1.9

6.1

337

F30.1

ICD-10 Finland

Mania without psychotic symptoms

6.4

6.0

E000003

ATC

1.4

6.0

243

1386

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

610

344

13.96

307.65

1.0

416.0

297.7

ng/l

9.35

449

194

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

617

345

14.09

307.65

1.0

57.8

40.6

ng/l

7.99

447

194

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

617

346

14.05

307.65

1.0

537.9

702.6

ng/l

8.58

440

189

(3019309) Folate [Moles/volume] in Red Blood Cells

5017

20899

2.31

307.65

2.0

1.8

1201.4

1160.4

nmol/l

2.10

3554

15422

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

574

1029

4.35

199.27

1.2

1.4

246.5

1239.9

e6/l

3.64

453

862

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

574

1029

4.35

199.27

1.2

1.3

11.8

21.7

e6/l

0.57

442

815

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

632

1222

4.04

199.23

1.1

1.3

468.8

600.8

mg/l

4.41

566

1155

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

566

1069

4.12

183.81

1.1

1.2

3.8

3.9

mmol/l

0.90

525

988

(3044290) Cell count panel - Cerebral spinal fluid

492

947

4.03

155.66

1.2

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

388

712

4.20

130.43

3.1

3.6

306.5

326.2

umol/l

1.56

302

575

(40768804) Tissue Pathology biopsy report

2494

28534

0.58

122.94

2.2

2.4

—

(3023410) Appearance of Cerebral spinal fluid

280

410

5.24

122.32

1.3

1.4

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

3410

17288

1.66

122.04

3.1

3.0

2.5

mmol/l

8.39

2900

14734

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1255

16772

0.52

103.11

1.5

1.6

1.2

1.3

mmol/l

2.32

1053

13639

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

6997

62361

0.67

101.68

3.8

4.8

1.4

mmol/l

0.48

5808

54801

(3015377) Calcium [Moles/volume] in Serum or Plasma

4979

28479

1.51

101.60

2.6

3.2

2.3

2.4

mmol/l

0.84

4111

23760

(3020682) Albumin/Creatinine [Ratio] in Urine

2411

26673

0.61

97.90

3.2

3.9

11.8

10.3

mg/mmol

0.64

1429

16791

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

6756

60339

0.68

95.73

3.4

4.3

1.2

mmol/l

1.97

5515

52374

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

7156

63137

0.68

93.84

3.8

4.8

4.3

mmol/l

1.50

5995

56008

(3012516) Albumin [Mass/volume] in Urine

2252

25039

0.61

92.00

2.6

3.2

491.2

391.9

mg/l

0.43

1357

15985

(3009508) Creatinine [Moles/volume] in Urine

2265

25075

0.61

90.50

2.5

3.1

7.0

6.6

mmol/l

2.83

1705

20245

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

6086

37332

1.42

80.01

2.5

2.2

89.6

92.6

pmol/l

5.21

3124

19201

(3031040) Bacteria [#/volume] in Urine by Automated count

8078

52541

1.41

72.92

6.3

5.6

3787.9

1523.5

e6/l

2.26

259

938

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

7625

65383

0.71

71.68

4.4

5.5

2.4

mmol/l

2.30

6433

57769

(3023368) Bacteria identified in Blood by Culture

4529

26836

1.41

69.07

4.0

4.3

—

(3026008) Bacteria identified in Urine by Culture

4991

30091

1.40

68.81

3.9

3.8

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

3446

19570

1.44

65.72

1.8

438.5

20164135.6

pmol/l

8.55

2657

15394

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

7250

62267

0.73

64.32

19.7

19.0

66.4

66.7

ml/min/173m2

0.65

5656

51991

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2150

11163

1.54

63.59

1.9

1.8

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2136

11218

1.52

59.51

1.9

1.8

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

647

9034

0.52

57.49

1.2

17.3

16.2

u/ml

0.09

159

2931

(3016018) Differential panel - Cerebral spinal fluid

219

483

3.46

57.19

1.2

1.3

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

5874

37162

1.34

55.99

3.7

4.4

34.0

33.9

g/l

0.46

5154

33855

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2853

16267

1.41

50.94

1.9

—

(4035726)

456

6799

0.49

49.14

1.3

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

753

9615

0.57

48.68

1.2

1.3

44.1

42.7

iu/ml

0.08

216

2956

(1761868) Lipid panel - Serum or Plasma

1433

15646

0.65

47.89

3.2

3.6

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1190

5757

1.61

46.73

1.6

1.5

—

(3021960) Folate [Moles/volume] in Serum or Plasma

3788

23016

1.34

44.37

1.7

1.6

20.1

20.2

nmol/l

0.11

3319

19305

(3019150) Specific gravity of Urine by Refractometry

2819

16513

1.36

41.46

5.6

5.0

1.0

kg/l

0.99

438

2782

(3037522) Nuclear Ab [Titer] in Serum

573

7493

0.56

39.90

1.2

1.3

447.5

532.0

titre

0.69

112

1767

(3002179) Metamyelocytes/100 leukocytes in Blood

413

5953

0.51

39.81

2.9

3.5

0.7

0.6

0.14

1419

(3017181) Myelocytes/100 leukocytes in Blood

486

6648

0.53

39.54

3.1

3.6

1.2

0.9

0.56

142

2047

(3021440) Promyelocytes/100 leukocytes in Blood

452

6318

0.52

39.50

3.1

3.6

0.2

0.1

0.82

128

1907

(3026493) Urate [Moles/volume] in Serum or Plasma

2070

20431

0.72

38.50

2.3

2.9

10206.7

7355.6

umol/l

1.17

1593

16885

(3021589) Normoblasts [#/volume] in Blood

3345

30715

0.76

37.92

9.4

10.9

0.0

e9/l

1.31

2632

24903

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3868

34794

0.77

37.30

4.0

4.4

—

(3002256) Pathology report gross observation

859

9955

0.63

36.84

1.4

—

(3025159) Blasts/100 leukocytes in Blood

421

5830

0.53

35.55

3.1

3.6

0.0

0.4

2.83

106

1576

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

7655

63249

0.79

35.06

6.3

7.0

42.7

41.5

mmol/mol

14.34

6530

56516

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

370

5286

0.51

34.54

1.3

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

686

3124

1.69

33.82

1.2

—

(3003694) ABO and Rh group [Type] in Blood

1569

15856

0.71

32.91

1.2

1.3

—

(3022145) Colonoscopy Study observation

622

7535

0.60

31.96

1.2

1.3

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

7987

65388

0.80

31.56

4.5

5.4

6.2

6.1

mmol/l

5.08

6635

57124

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

4701

30494

1.25

30.12

2.1

2.2

78.2

80.8

nmol/l

6.59

3873

26019

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

874

9633

0.66

29.14

4.1

4.9

34.3

0.02

450

6095

(40768797) Stomach Pathology biopsy report

913

9963

0.67

28.94

1.2

1.3

—

(3006504) Eosinophils/100 leukocytes in Blood

3837

33721

0.80

27.66

4.5

5.5

2.8

0.07

3388

30779

(3018010) Neutrophils/100 leukocytes in Blood

3838

33724

0.80

27.61

4.6

5.5

61.4

59.8

10.85

3389

30811

(3006315) Basophils [#/volume] in Blood

4105

35800

0.80

27.55

4.3

5.2

0.0

e9/l

1.92

3367

30096

(3022096) Basophils/100 leukocytes in Blood

3731

32877

0.80

27.51

4.5

5.5

0.6

3.09

3290

30059

(3019069) Monocytes/100 leukocytes in Blood

3860

33885

0.80

27.49

4.8

5.8

8.9

9.0

0.68

3412

31010

(3001604) Monocytes [#/volume] in Blood

4077

35527

0.80

26.96

4.3

5.2

0.6

e9/l

0.41

3337

29818

(3013512) EKG study

2797

25419

0.78

26.75

4.4

4.8

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

5884

39441

1.22

26.69

4.5

5.8

1.2

mmol/l

3.57

5082

35101

(3013115) Eosinophils [#/volume] in Blood

4248

36811

0.81

26.50

4.4

5.3

0.2

e9/l

0.11

3471

31355

(3018418) pH of Serum or Plasma

4026

25954

1.24

26.31

3.0

4.0

7.4

1.25

639

4947

(3002030) Lymphocytes/100 leukocytes in Blood

3947

34367

0.81

25.42

4.8

5.8

23.3

24.7

10.54

3454

31239

(3019198) Lymphocytes [#/volume] in Blood

4209

36334

0.81

24.71

4.4

5.3

1.7

1.9

e9/l

2.26

3467

31005

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

5207

34650

1.22

24.68

4.7

4.6

59.5

95.0

ng/l

1.58

4093

28061

(3000492) Spirometry study

364

4733

0.57

24.46

1.4

1.6

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

4897

41599

0.82

24.33

5.8

8.0

4.8

4.5

e9/l

11.26

4089

35647

(40760892) CBC W Ordered Manual Differential panel - Blood

1384

13612

0.74

23.49

3.6

4.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

429

5287

0.60

23.42

1.5

—

(4010399)

413

5136

0.59

23.37

1.4

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

4012

26105

1.23

23.36

2.3

2.1

264.0

222.5

u/l

2.06

3655

24202

(40761535) Cells panel - Urine sediment

1307

7381

1.37

22.94

4.0

3.8

—

(3029937) Albumin [Presence] in Urine by Test strip

3181

20262

1.24

22.44

5.3

4.9

0.0

estimate

1.15

692

6499

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

973

10027

0.71

22.10

2.6

3.6

21.1

23.0

ug/l

0.09

777

8407

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2074

19116

0.78

21.39

2.3

2.5

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

4290

28316

1.21

21.10

2.6

2.1

—

(3003338) MCHC [Mass/volume]

7363

51084

1.20

20.97

27.3

26.7

329.5

330.0

g/l

4.95

7129

50376

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

483

2296

1.61

20.16

1.4

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

442

5215

0.63

20.02

1.3

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

482

2296

1.60

19.95

1.4

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1038

10371

0.73

19.25

1.4

1.5

2.8

g/l

0.05

467

5582

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

6356

43761

1.18

18.80

5.1

6.4

1.2

mmol/l

14.08

5056

36265

(3044640) Blood type and Crossmatch panel - Blood

2898

25450

0.82

18.71

2.4

2.6

—

(3028026) IgM [Mass/volume] in Serum or Plasma

297

3765

0.59

18.11

1.8

1.6

1.5

g/l

0.15

227

3321

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

214

2948

0.54

17.65

2.9

3.9

264.4

82.8

u/ml

1.52

198

2801

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1169

11341

0.76

17.58

2.6

3.5

251.4

251.9

u/l

0.04

1003

10542

(3013139) Helicobacter pylori Ag [Presence] in Stool

356

4283

0.62

17.54

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

155

538

2.19

17.43

2.4

2.3

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

556

6037

0.68

16.79

3.0

2.9

56.8

55.4

ml/min/173m2

0.45

233

2855

(42870588) Differential panel, method unspecified - Blood

2958

25711

0.83

16.75

4.1

5.2

—

(3015736) pH of Urine

4342

29153

1.18

16.61

4.5

4.2

—

5.8

—

(3005719) IgG [Mass/volume] in Serum or Plasma

405

4672

0.64

16.54

2.5

2.6

10.7

10.8

g/l

0.09

329

4208

(40768443) Skin Pathology biopsy report

292

3623

0.60

16.36

1.2

—

(4094501)

1611

0.42

15.59

1.1

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

4120

27734

1.17

14.85

5.4

5.0

—

(3022217) INR in Platelet poor plasma by Coagulation assay

2328

14911

1.21

14.65

30.9

33.4

1.7

1.6

inr

1.85

158

1998

(3052592) Norovirus Ag [Presence] in Stool

220

2.72

14.31

1.4

1.2

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

9450

67878

1.17

14.26

20.6

19.6

33.1

28.4

mg/l

25.45

8132

57237

(3020779) Urea [Moles/volume] in Serum or Plasma

878

8619

0.75

14.22

4.0

5.7

12.0

12.3

mmol/l

0.46

787

8007

(3000494) Fungus identified in Specimen by Culture

778

7739

0.74

13.81

1.3

1.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

2730

17899

1.19

13.18

4.8

4.3

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

203

2603

0.58

13.01

1.4

1.6

37.1

38.2

u/l

0.29

146

2149

(3045414) Leukocytes [Presence] in Urine

286

3373

0.63

12.96

2.2

2.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1501

9294

1.25

12.95

2.5

5.2

6.0

ug/l

1.34

1067

7725

(3024891) Influenza virus A+B Ag [Presence] in Specimen

348

1706

1.55

12.87

1.3

1.2

—

(3014271) Vancomycin [Susceptibility]

189

789

1.82

12.81

3.5

3.1

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1172

7070

1.27

12.64

1.6

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

807

0.28

12.50

1.4

1.5

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1828

16233

0.82

12.39

2.9

3.5

0.9

ug/l

0.21

1292

12028

(3037467) Urinalysis macro (dipstick) panel - Urine

7393

52381

1.14

12.38

5.2

5.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

130

1865

0.52

12.38

1.9

2.7

271.6

736.1

u/ml

1.42

109

1695

(3019832) Treponema pallidum Ab [Presence] in Serum

255

1179

1.64

12.06

1.1

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1647

10393

1.22

11.84

10.6

9.4

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1431

0.47

11.71

1.2

4.4

5.1

u/ml

0.17

245

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

217

2657

0.61

11.60

1.6

112.5

244.8

titre

2.14

136

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1294

0.45

11.42

1.5

1.8

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1314

11970

0.81

11.41

3.5

4.9

1.0

mmol/l

0.37

1102

10816

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1053

6348

1.27

11.40

1.9

1.7

—

(40768793) Breast Pathology biopsy report

1413

0.48

11.31

1.2

1.3

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1412

0.48

11.29

1.2

1.4

6.5

u/ml

—

152

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

3626

24585

1.15

11.16

2.3

2.4

3.1

3.2

mg/l

2.26

2888

20652

(3015171) Extractable nuclear Ab [Units/volume] in Serum

162

2094

0.58

10.77

1.2

0.5

1.0

u/ml

0.69

208

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

645

3667

1.34

10.77

1.5

1.6

1.7

0.28

521

2907

(3005322) IgE [Units/volume] in Serum or Plasma

228

2711

0.63

10.77

1.2

289.2

242.3

u/ml

0.44

202

2446

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

175

2208

0.59

10.60

1.5

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

126

1730

0.54

10.44

1.6

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

104

1510

0.52

10.37

1.2

3.6

44.7

u/ml

—

(3048689) Calprotectin [Mass/mass] in Stool

617

6088

0.75

10.32

1.7

1.8

176.6

176.3

ug/g

0.00

434

4564

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3929

32448

0.88

10.32

3.0

3.4

2490.4

2176.0

ng/l

2.71

3216

28410

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

118

459

1.95

10.03

1.1

—

3.3

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

348

2.09

9.90

1.0

1.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1219

0.48

9.74

1.2

1.1

6.6

u/ml

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

120

1636

0.55

9.73

1.5

1.6

13.2

12.6

mg/l

0.28

1469

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

1194

0.48

9.64

1.1

—

(3006270) Folate [Moles/volume] in Blood

192

879

1.66

9.54

1.2

315.5

305.8

nmol/l

0.24

146

643

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

131

1725

0.57

9.40

1.2

—

(3009542) Hematocrit [Volume Fraction] of Blood

7836

56211

1.12

9.33

22.9

21.5

36.2

37.0

5.82

3990

31503

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1017

6252

1.24

9.31

4.9

6.1

24.5

mmol/l

0.01

963

5821

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1325

11814

0.83

9.16

1.2

1.7

u/ml

0.06

281

2777

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

573

0.28

9.11

1.9

1.5

—

(3035350) Ketones [Presence] in Urine by Test strip

5207

36516

1.12

9.03

4.8

4.4

0.0

estimate

0.00

780

6941

(40768795) Lymph node Pathology biopsy report

707

0.35

8.97

1.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

302

3242

0.70

8.65

2.1

2.8

406.1

2826.3

u/ml

1.91

224

2745

(3045424) Erythrocytes [Presence] in Urine

1216

0.51

8.60

1.4

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1510

13216

0.84

8.43

2.2

2.6

19.7

20.6

1.65

1085

10996

(3042631) Mycobacterium sp identified in Specimen

111

1482

0.56

8.42

2.3

2.7

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

118

1549

0.57

8.42

2.5

2.1

210.8

215.0

0.20

107

1452

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

138

1737

0.59

8.38

1.4

1.1

g/l

0.12

125

1622

(4027681)

156

2.52

8.32

1.1

1.2

—

(40757373) Influenza virus identified in Isolate

193

2.35

8.29

1.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

331

3464

0.71

8.19

2.6

2.7

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

228

2.22

8.15

3.0

2.8

26.9

29.7

umol/l

1.30

165

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

137

601

1.73

8.04

1.3

1.2

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

6639

47388

1.11

8.03

4.4

4.7

7.2

6.9

mmol/l

9.89

6197

44567

(3007566) Smooth muscle Ab [Titer] in Serum

110

1440

0.57

7.80

1.1

70.0

136.5

titre

—

(3004809) Band form neutrophils/100 leukocytes in Blood

126

1586

0.59

7.69

3.9

3.4

2.5

1.5

1.03

1189

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1289

0.55

7.68

1.2

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

137

1688

0.61

7.66

1.4

0.2

g/l

0.12

124

1573

(3000330) Specific gravity of Urine by Test strip

534

5154

0.77

7.61

4.4

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

893

0.47

7.52

1.2

1.3

0.6

0.7

nmol/l

0.91

846

(40768800) Prostate Pathology biopsy report

155

1847

0.63

7.52

1.2

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1622

13990

0.86

7.50

2.1

2.5

2.2

g/l

5.16

1388

12688

(3017354) Segmented neutrophils/100 leukocytes in Blood

972

0.49

7.47

3.1

3.4

56.7

60.6

0.41

578

(3042936) Bacteria identified in Isolate by Culture

1343

11749

0.85

7.41

1.8

2.0

—

(21494755) Public health laboratory ask at order entry panel

564

0.35

7.35

1.3

1.4

—

(3045142) Bone marrow Pathology biopsy report

893

0.48

7.30

1.2

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

470

4582

0.76

7.25

1.4

—

(3009261) Glucose [Presence] in Urine by Test strip

5229

36987

1.11

7.23

4.9

4.5

0.0

estimate

1.08

760

6845

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

8995

70062

0.90

7.14

9.0

11.5

22.7

23.0

u/l

0.22

8248

66535

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

355

1967

1.37

7.13

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

782

0.45

7.12

1.1

1.3

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2627

17896

1.13

7.03

4.4

253.5

429.1

ng/l

1.90

2369

15997

(3042111) Morphology [Interpretation] in Bone marrow Narrative

132

1603

0.62

6.99

1.4

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1108

0.54

6.99

3.8

3.6

225.6

2934.9

iu/ml

0.98

158

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

153

1796

0.64

6.97

1.8

2.1

3.6

g/l

0.17

141

1685

(4281824)

739

0.45

6.86

1.2

—

(3008898) HLA-B27 [Presence]

872

0.49

6.84

1.0

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

872

0.49

6.84

2.0

2.1

80.3

992.4

u/ml

1.51

855

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

261

2752

0.71

6.82

1.1

57.2

127.0

iu/ml

3.72

900

(3021601) Nitrite [Presence] in Urine by Test strip

5148

36472

1.10

6.75

6.2

6.0

0.0

estimate

0.50

752

6909

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

826

0.48

6.72

1.2

1.3

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

356

1993

1.36

6.72

1.2

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

138

1642

0.63

6.70

1.8

2.0

90.3

87.0

1.24

126

1549

(42529406) Shigella sp [Presence] in Stool by Culture

356

1995

1.35

6.68

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

810

0.48

6.59

1.2

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

217

0.17

6.48

1.0

1.2

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

459

4413

0.78

6.39

1.4

—

(3023183) Ammonium ion [Moles/volume] in Plasma

283

1546

1.39

6.25

1.5

2.0

27.2

32.1

umol/l

3.26

219

1216

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1600

13633

0.87

6.21

2.2

2.6

0.8

mmol/l

0.51

1366

12399

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

569

5307

0.80

6.13

2.4

2.6

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

819

0.50

6.13

1.5

0.8

g/l

0.07

613

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

247

1.99

6.08

1.1

40.2

46.2

mg/l

0.57

207

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

426

1.74

6.06

1.1

1.2

2.0

2.2

mmol/l

2.18

385

(3034860) Kappa light chains.free [Mass/volume] in Serum

371

3635

0.76

6.00

2.6

2.8

55.0

89.3

mg/l

1.19

285

2953

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

370

3626

0.76

5.99

2.6

2.8

48.8

54.9

mg/l

0.30

288

2942

(3039000) Anion gap in Blood

353

2017

1.33

5.87

4.4

5.8

11.4

11.3

mmol/l

0.12

322

1800

(3018572) Chloride [Moles/volume] in Blood

353

2017

1.33

5.87

4.5

5.8

104.6

104.9

mmol/l

0.42

322

1800

(3043409) Potassium [Moles/volume] in Arterial blood

498

2986

1.27

5.76

3.0

3.9

mmol/l

0.45

441

2766

(3044889) 12 lead EKG panel

6335

49936

0.92

5.69

4.6

4.8

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

270

2740

0.74

5.62

1.2

—

(3017732) Neutrophils [#/volume] in Blood

485

4557

0.79

5.61

3.2

3.3

4.6

4.3

e9/l

0.75

286

3044

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

988

0.57

5.58

1.2

87.2

46.8

u/ml

—

112

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1875

15700

0.88

5.54

1.5

1.7

1.9

1.6

mg/l

1.66

1413

12394

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

539

4998

0.80

5.54

4.3

7.0

24.1

24.4

mmol/l

0.67

471

4544

(3023419) Bacteria identified in Sputum by Culture

1164

0.61

5.50

1.7

2.4

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1375

9113

1.15

5.48

4.6

4.0

—

(3006653) Thiamine [Moles/volume] in Blood

284

1.86

5.46

1.1

132.4

134.9

nmol/l

0.14

284

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

520

0.42

5.44

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

170

1852

0.69

5.44

2.6

2.5

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

334

1.79

5.41

1.2

0.7

0.9

promille

1.03

245

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

124

1435

0.65

5.39

2.6

3.1

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

437

4133

0.79

5.36

1.9

2.2

3.9

3.8

g/l

0.47

263

2818

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

103

1240

0.62

5.36

1.5

1.7

18.1

24.0

ug/l

1.46

1200

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

587

0.46

5.29

3.1

3.6

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

440

4149

0.79

5.27

1.9

2.2

7.7

7.6

g/l

0.51

270

2923

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

225

2322

0.73

5.25

1.3

1.4

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

166

1803

0.69

5.24

2.4

1.8

1.9

mg/l

0.57

129

1563

(3017446) Testosterone [Moles/volume] in Serum or Plasma

384

3675

0.78

5.22

1.9

2.0

9.5

10.2

nmol/l

0.94

306

3027

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

440

4143

0.79

5.21

1.9

2.2

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

366

3521

0.78

5.19

2.6

2.8

3.7

2.7

ratio

0.38

258

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

254

2565

0.74

5.15

1.6

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

780

0.54

5.11

1.2

1.3

—

nmol/l

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

844

0.56

5.03

1.7

2.0

679.2

1924.3

u/ml

—

(3022313) Gas panel - Capillary blood

463

4312

0.80

4.98

3.1

3.9

—

(3036603) Volume of Urine

499

0.44

4.94

2.6

1.5

1719.5

1804.6

0.13

161

(3020630) Protein [Mass/volume] in Serum or Plasma

995

8632

0.86

4.93

2.0

2.4

65.1

65.7

g/l

1.32

789

7593

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

414

3899

0.79

4.93

1.8

2.2

10.5

10.4

g/l

0.19

294

3167

(4024509)

942

0.59

4.89

1.4

1.7

—

(3011985) Renin [Units/volume] in Plasma

827

0.56

4.89

1.1

1.3

30.0

54.7

mu/l

1.44

717

(3005988) Vibrio sp identified in Specimen by Organism specific culture

1062

0.61

4.85

1.2

1.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

1069

0.62

4.81

1.2

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

1087

0.62

4.80

1.2

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

1059

0.62

4.80

1.2

1.3

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1804

15015

0.89

4.79

2.1

2.5

10.6

11.4

umol/l

4.89

1525

13627

(3025468) Yersinia sp identified in Specimen by Organism specific culture

1058

0.62

4.78

1.2

1.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

376

2233

1.28

4.77

1.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

1057

0.62

4.76

1.2

1.3

—

(3013707) Erythrocyte sedimentation rate by Westergren method

6770

53001

0.92

4.76

3.7

4.4

16.8

16.2

mm/h

1.75

5844

47899

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

654

0.52

4.75

1.5

1.7

4.4

5.0

mg/l

0.44

611

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

404

3797

0.80

4.74

1.9

2.2

3.2

3.1

g/l

0.49

265

2872

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

256

2548

0.75

4.73

1.9

1.6

—

(40768441) Liver Pathology biopsy report

392

0.38

4.69

1.0

1.2

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

523

3239

1.23

4.61

1.9

2.2

1126.9

571.8

ug/l

0.72

477

3063

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

860

0.59

4.60

1.2

—

16.2

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

230

1.87

4.58

1.0

1.1

294.3

321.8

mg/l

0.40

200

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

203

2079

0.73

4.57

1.9

1.6

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

319

0.33

4.54

1.2

1.1

—

(3047181) Lactate [Moles/volume] in Blood

459

2812

1.24

4.49

4.4

5.3

1.4

mmol/l

0.62

409

2486

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

1050

0.63

4.48

1.4

1.5

74.2

64.8

2.02

663

(21494890) Protein electrophoresis panel - 24 hour Urine

1057

0.63

4.44

2.0

1.8

—

(21494814) CD8 cells/100 lymphocytes in Specimen

223

0.30

4.43

4.2

1.7

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

162

1711

0.71

4.43

1.4

1.5

57.5

5.7

iu/ml

1.07

462

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

239

1.83

4.39

1.2

1.5

75.9

100.9

umol/l

0.63

143

(3018095) Leukocytes [#/volume] in Urine

4172

29719

1.08

4.33

4.2

4.1

208.6

145.0

e6/l

1.47

3039

22062

(3019225) pH of Specimen

1075

9181

0.87

4.30

4.3

4.5

—

(21494434) Karyotype in Bone marrow

795

0.59

4.27

1.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

510

0.49

4.25

1.9

2.2

40.1

93.6

ug/min

—

122

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

1063

0.64

4.23

3.1

3.5

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

232

1.82

4.18

2.5

2.0

56.9

56.6

umol/l

0.02

168

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1069

0.65

4.18

1.5

1.4

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

2.33

4.11

1.1

1.2

20.8

49.4

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

137

1459

0.70

3.98

1.3

47.9

40.3

u/l

0.25

112

1241

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

135

706

1.45

3.97

1.3

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

954

0.64

3.94

1.2

1.1

—

(3011412) CD3 cells [#/volume] in Blood

505

0.51

3.92

3.0

1.7

1.0

e9/l

0.02

324

(40761511) CBC panel - Blood by Automated count

9206

67732

1.08

3.91

19.8

19.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

766

0.60

3.91

1.1

1.2

229.4

255.6

pmol/l

0.48

573

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

1060

0.66

3.89

2.7

3.6

34.5

43.7

u/ml

0.51

1028

(3035637) Corticotropin [Mass/volume] in Plasma

717

0.59

3.88

1.1

1.4

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

875

0.63

3.85

1.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

818

0.62

3.83

1.0

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

709

6178

0.86

3.77

2.9

3.7

5.2

kpa

0.51

613

5612

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

2.39

3.77

2.2

2.4

148.2

136.1

nmol/l

0.30

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

205

0.33

3.75

4.2

1.6

—

(3009343) pH of Capillary blood

700

6102

0.86

3.75

2.9

3.7

7.4

0.78

804

(3028707) Methadone [Presence] in Urine by Screen method

2.34

3.74

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

132

697

1.43

3.71

1.3

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

727

0.60

3.71

1.1

—

(3004588) Protein electrophoresis panel - Serum or Plasma

844

7251

0.87

3.71

2.1

2.3

—

(4015189)

261

0.35

3.62

1.8

2.2

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

124

1319

0.71

3.61

1.2

—

(40760888) Immunoglobulin light chains.free panel - Serum

287

2709

0.79

3.59

2.7

2.9

—

(3007916) DNA double strand Ab [Titer] in Serum

0.00

3.57

0.0

1.2

—

80.6

—

(3021788) Differential panel - Synovial fluid

148

1522

0.73

3.52

1.4

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

256

0.35

3.49

1.8

1.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

105

1142

0.69

3.49

1.2

1.3

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

5253

41218

0.93

3.47

3.9

5.7

12.9

12.6

umol/l

0.77

4723

38904

(3020650) Glucose [Presence] in Urine

147

0.26

3.45

1.2

1.5

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

9652

71261

1.08

3.44

24.5

23.9

139.7

139.4

mmol/l

13.91

9185

69215

(3001019) Free T4 and TSH panel - Serum or Plasma

589

0.57

3.44

1.5

1.7

—

(3003434) Protein [Mass/volume] in Pleural fluid

187

1851

0.76

3.43

1.4

1.5

29.9

30.7

g/l

0.45

166

1636

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

329

0.43

3.41

1.1

1.5

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

329

0.43

3.41

1.1

1.5

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

9659

71324

1.08

3.41

24.5

24.1

4.0

mmol/l

1.84

9168

69166

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2510

20232

0.92

3.41

2.5

3.0

36.1

37.3

u/l

0.29

2269

18872

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

275

0.38

3.41

1.0

1.1

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

837

0.65

3.36

1.1

1.2

54.9

60.5

u/l

0.38

561

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

429

0.51

3.36

1.1

1.5

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

429

0.51

3.36

1.1

1.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

429

0.51

3.36

1.1

1.5

—

(3018405) Lactate [Moles/volume] in Arterial blood

544

3495

1.18

3.34

3.0

3.6

1.5

1.4

mmol/l

0.78

535

3425

(3025130) Human papilloma virus identified in Specimen

294

0.41

3.34

2.1

1.5

—

(1617658) Protocol used for examination of sentinel lymph nodes

497

0.54

3.34

1.1

1.0

—

(4146454)

989

0.68

3.33

2.4

2.6

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

594

5189

0.86

3.30

1.5

1.6

g/l

0.54

447

4392

(3047189) Immunofixation for 24 hour Urine

453

0.53

3.24

1.1

1.4

—

(3002582) Erythrocytes [#/volume] in Urine

3711

26559

1.07

3.23

3.7

3.6

118.6

122.1

e6/l

0.04

2893

20834

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

131

1.96

3.22

3.5

3.0

0.4

0.5

u/field

0.36

131

(3048929) Epstein Barr virus Ab [Presence] in Serum

899

0.67

3.19

1.1

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

508

0.56

3.17

1.2

1.3

2.7

2.9

g/l

0.38

361

(3027135) IgG subclass 1 [Mass/volume] in Serum

508

0.56

3.17

1.2

1.3

6.8

7.1

g/l

0.25

356

(3024139) IgG subclass 3 [Mass/volume] in Serum

508

0.56

3.17

1.2

1.3

0.5

g/l

0.01

361

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

546

0.58

3.16

1.3

1.2

7.3

8.2

mmol/l

1.31

338

(3009214) Lutropin [Units/volume] in Serum or Plasma

630

0.61

3.14

1.3

14.4

13.3

u/l

0.18

491

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

181

1773

0.77

3.11

1.2

1.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

581

0.60

3.10

1.2

1.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

811

0.66

3.08

1.4

1.5

15.4

26.4

4.25

506

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

383

3448

0.83

3.07

1.8

2.3

1.4

1.2

g/l

0.28

274

2837

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

686

5893

0.87

3.06

2.9

3.7

2.0

2.1

mmol/l

0.21

483

4306

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

333

0.47

3.02

1.2

1.6

—

(4062490)

510

0.58

3.02

1.3

—

(3019060) Gas panel - Arterial blood

998

6748

1.12

3.01

3.5

4.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

113

1179

0.72

3.00

1.3

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

362

0.50

2.99

1.0

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

508

0.58

2.98

1.0

1.1

119.3

113.7

0.63

433

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

325

2960

0.82

2.96

1.8

2.2

0.0

g/l

1.08

254

2653

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

420

0.54

2.96

1.1

115.9

91.1

u/l

0.58

306

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

219

1.69

2.94

1.0

1.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

118

1218

0.73

2.94

1.2

1.3

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

702

0.64

2.94

1.1

100.2

428.8

iu/ml

—

106

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

419

0.54

2.94

1.1

60.3

31.2

u/l

0.76

296

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

223

0.37

2.92

1.5

2.6

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

398

0.53

2.91

1.1

1.4

4.0

3.4

—

(3037121) Protein [Mass/volume] in Urine

343

3101

0.83

2.90

2.4

2.7

0.3

g/l

0.10

110

1177

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

427

0.55

2.90

1.1

1.5

—

(40765096) Chromosome analysis panel by Banding

232

0.39

2.87

1.3

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

958

0.70

2.86

1.1

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

336

0.49

2.86

1.0

285.4

294.5

mg/l

0.23

292

(3010813) Leukocytes [#/volume] in Blood

9709

71852

1.07

2.86

28.4

28.9

7.4

7.1

e9/l

8.55

9122

68997

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

742

0.66

2.85

1.2

116.7

118.1

u/ml

0.05

175

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

705

0.65

2.84

1.2

1.4

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

705

0.65

2.84

1.2

1.4

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

705

0.65

2.84

1.2

1.4

—

(3036782) Glucose [Moles/volume] in Pleural fluid

115

1183

0.73

2.82

1.3

1.4

6.3

6.4

mmol/l

0.16

1107

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

399

3549

0.84

2.82

3.3

4.2

25.0

24.9

mmol/l

0.34

325

3164

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

283

0.45

2.82

1.8

2.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

704

0.65

2.82

1.1

1.0

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

142

1415

0.75

2.81

1.4

1.3

—

(3000991) Gas panel - Venous blood

931

7798

0.89

2.79

3.6

6.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

675

0.65

2.79

1.1

273.1

300.4

u/ml

0.32

386

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

350

3143

0.83

2.77

1.2

1.3

50.0

54.5

au/ml

0.10

128

(44813793)

291

0.47

2.76

1.0

1.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

208

1239

1.27

2.75

11.8

14.6

8.0

7.4

mmol/l

1.17

164

1010

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

244

2264

0.81

2.71

2.0

2.2

84.8

99.2

ug/min

0.26

121

1253

(3035941) MCH [Entitic mass]

9701

71835

1.07

2.70

28.3

28.7

30.3

30.4

3.25

9267

70173

(3049717) Cytology report of Urine Cyto stain

499

4341

0.86

2.69

2.7

2.9

—

(3051593) INR in Capillary blood by Coagulation assay

687

0.66

2.69

9.2

12.9

—

(3026361) Erythrocytes [#/volume] in Blood

9701

71839

1.07

2.69

28.4

28.9

4.2

4.3

e12/l

46.09

9104

68958

(3008757) Leukocyte morphology finding [Identifier] in Blood

1025

0.72

2.69

5.1

3.7

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2930

23283

0.93

2.68

4.4

5.0

21.5

22.6

3.66

1437

13019

(3004775) Volume in Urine collected for unspecified duration

794

0.68

2.67

2.1

675.0

645.3

0.21

487

(3007461) Platelets [#/volume] in Blood

9699

71831

1.07

2.66

28.4

28.8

235.9

236.0

e9/l

0.07

9158

69303

(3024731) MCV [Entitic volume]

9700

71839

1.07

2.66

28.3

28.8

91.9

92.0

1.39

9270

70178

(3000963) Hemoglobin [Mass/volume] in Blood

9701

71849

1.07

2.65

28.6

29.1

126.7

129.6

g/l

63.93

9249

70203

(3024354) Oxygen [Partial pressure] in Venous blood

1139

7821

1.11

2.63

2.4

3.1

4.1

4.3

kpa

3.37

1077

7520

(3000475) Leukocytes [#/volume] in Synovial fluid

217

2031

0.80

2.62

1.5

1.6

24777.0

14932.5

e6/l

1.01

152

1451

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

498

0.60

2.61

1.2

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

498

0.60

2.61

1.2

1.4

—

(36304419) Bacteria [Presence] in Urine

3206

22980

1.07

2.61

3.5

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

126

0.30

2.60

13.8

12.8

5.7

5.5

mmol/l

—

126

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

412

0.57

2.60

1.0

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

323

1.52

2.59

1.1

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

300

2713

0.83

2.59

1.8

2.2

0.0

g/l

0.00

240

2460

(3012441) Differential panel - Pleural fluid

141

1388

0.76

2.59

1.4

1.5

—

(3037556) Urate [Mass/volume] in Serum or Plasma

273

0.47

2.59

1.9

1.5

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

311

1.53

2.58

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

162

0.37

2.58

1.0

—

1.8

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

149

0.35

2.58

4.6

1.8

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

382

0.55

2.58

2.6

1.7

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

140

0.32

2.57

1.0

1.3

—

1.5

—

(3012565) Volume of 24 hour Urine

362

0.54

2.56

1.8

2.3

1627.1

1783.6

0.28

298

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

901

0.71

2.55

1.6

1.5

2.2

2.9

mg/l

0.63

685

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

124

1239

0.75

2.54

1.3

407.3

397.4

u/l

0.05

109

1170

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

127

1.84

2.52

2.3

2.1

—

(3014007) Fractional oxyhemoglobin in Arterial blood

680

5763

0.88

2.52

4.3

7.1

92.5

93.6

2.92

674

5738

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

379

0.56

2.51

2.5

1.7

16.6

15.6

0.12

143

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

435

3800

0.86

2.50

2.1

2.5

0.4

0.3

u/ml

0.77

248

2171

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

407

0.57

2.50

1.1

1.2

12.7

12.3

mmol/l

—

127

(3023520) Reticulocytes [#/volume] in Blood

1129

9299

0.91

2.49

2.2

2.4

65.2

66.9

e9/l

0.84

846

7099

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

4807

37544

0.94

2.48

2.8

3.1

52.4

57.5

u/l

2.71

4096

33460

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

263

2397

0.82

2.48

1.0

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

122

0.31

2.46

9.0

8.5

—

(4198724)

2.65

2.46

1.0

—

(3048879) Bone marrow aspiration report

326

0.53

2.43

1.0

1.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

316

1.50

2.42

1.7

2.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

316

1.50

2.42

1.7

2.2

—

(3017569) Oxygen content in Arterial blood

524

0.63

2.40

2.5

1.9

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

315

0.53

2.40

1.2

1.1

0.4

0.9

u/ml

—

108

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

309

2763

0.84

2.38

1.8

2.2

0.0

g/l

0.26

240

2471

(4306422)

521

0.64

2.35

1.2

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

399

0.58

2.34

1.0

1.1

96.4

90.1

0.90

359

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

807

0.71

2.33

1.3

1.2

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

585

4976

0.88

2.32

1.3

1.4

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

6868

50460

1.05

2.31

3.6

4.0

15.2

15.3

pmol/l

0.99

5820

44126

(3039443) Prostate specific Ag panel - Serum or Plasma

555

0.65

2.31

1.6

1.7

—

(3028626) Oxygen [Partial pressure] in Capillary blood

267

2411

0.83

2.31

2.3

2.9

7.4

7.7

kpa

2.19

255

2225

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

330

0.55

2.30

6.9

5.1

48.9

73.0

1.93

258

(3016750) Collection duration of Urine

536

0.65

2.29

2.2

1.9

496.4

501.0

min

0.09

366

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

2.29

0.0

1.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

363

3189

0.85

2.28

1.7

2.1

36.1

36.6

g/l

0.76

252

2611

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

357

0.57

2.26

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

356

0.57

2.24

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

356

0.57

2.24

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

356

0.57

2.24

1.1

—

(3032080) INR in Blood by Coagulation assay

4864

37897

0.95

2.24

11.2

12.3

1.4

inr

2.97

1175

10153

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

127

1.78

2.24

2.4

2.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

132

1282

0.77

2.24

1.3

—

(4268621)

365

0.58

2.23

2.0

2.2

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1406

9832

1.09

2.23

3.5

3.2

280.0

290.3

ng/l

0.30

1283

9034

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

152

1450

0.79

2.23

2.4

3.4

61.4

59.7

0.84

152

1450

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

355

0.57

2.22

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

355

0.57

2.22

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

116

1144

0.76

2.21

1.2

—

(3032057) Clostridioides difficile [Presence] in Stool

250

1.54

2.21

1.6

1.8

—

(3043410) Blood group antigens tested for on Red Blood Cells

266

0.51

2.20

2.1

1.8

—

(40768806) Pleura Pathology biopsy report

144

1379

0.78

2.19

1.4

1.6

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

8320

61485

1.05

2.18

4.8

5.0

2.0

2.1

mu/l

2.43

7203

54145

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

502

0.64

2.18

1.5

1.7

163.1

188.8

pmol/l

1.34

447

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

2.12

2.17

1.1

24.0

14.0

pmol/l

0.95

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

483

0.64

2.17

1.1

1.2

100.0

133.7

titre

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

333

0.56

2.17

2.4

1.8

413.0

538.4

e6/l

—

141

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

600

0.68

2.15

1.1

1.2

1.6

3.8

u/ml

1.97

183

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

573

0.67

2.15

1.1

1.2

5.8

4.3

u/ml

0.26

257

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

715

0.70

2.15

1.1

—

u/ml

—

(36660697) Celiac disease serology panel - Serum

487

4166

0.88

2.13

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

326

1.46

2.13

1.2

1.3

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

678

0.70

2.12

1.1

1.2

—

(44806420)

406

0.61

2.11

2.0

2.5

—

(3036489) Thrombin time

262

2348

0.84

2.11

1.7

1.8

21.6

22.1

0.30

236

2141

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

461

0.64

2.10

1.0

1.1

1.0

4.6

u/ml

—

(3028717) Thiamine [Mass/volume] in Blood

2.19

2.10

1.1

1.2

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

210

0.47

2.07

1.2

1.5

7.5

10.9

ug/l

1.12

188

(3017817) Protein [Mass] in Urine collected for unspecified duration

806

0.73

2.07

2.1

1.9

—

0.4

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

495

0.65

2.06

1.6

1.5

4.7

6.8

u/l

0.58

225

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

199

0.45

2.05

2.9

2.1

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

279

0.54

2.05

2.0

1.8

870.5

1649.6

u/ml

2.91

269

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

119

1156

0.77

2.05

1.2

1.3

0.9

0.8

nmol/l

0.43

928

(3014576) Chloride [Moles/volume] in Serum or Plasma

1458

11768

0.93

2.05

4.0

5.8

104.5

104.2

mmol/l

1.54

1387

11469

(4133840)

113

0.33

2.04

1.6

1.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

198

0.46

2.03

1.3

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.30

2.03

1.0

1.1

—

(3026470) Cobalt [Mass/volume] in Blood

644

0.70

2.01

1.7

1.8

2.5

4.3

ug/l

1.72

555

(1002224) Polysomnography panel

931

0.75

2.01

1.0

1.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

154

0.44

1.99

4.2

2.3

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

186

0.45

1.99

4.7

1.6

206.4

183.8

0.22

165

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

187

1149

1.23

1.99

1.8

1.6

—

(3003327) Ova and parasites identified in Stool by Light microscopy

171

1586

0.81

1.99

1.5

1.6

—

(3004451) EKG impression Narrative

553

0.68

1.98

1.3

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

719

0.72

1.95

1.3

1.2

—

(3019174) dRVVT (LA screen)

0.00

1.92

0.0

1.2

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

301

0.58

1.91

2.1

2.5

37.1

36.8

—

115

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

1.89

0.0

1.0

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

110

1065

0.78

1.88

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

236

1.50

1.87

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

528

0.68

1.86

1.0

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

738

0.73

1.85

1.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

307

0.59

1.84

1.0

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

3737

29191

0.95

1.83

4.5

5.8

7.1

5.1

ug/l

0.59

3077

25439

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

258

0.55

1.81

2.8

2.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

119

1.71

1.81

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

248

0.55

1.81

1.2

1.1

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1971

14073

1.07

1.80

3.2

3.3

2.8

e6/l

0.05

1102

8053

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

647

0.72

1.79

1.2

1.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

707

0.73

1.78

1.2

1.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

391

1.37

1.76

1.1

1.3

—

(3008037) Lactate [Moles/volume] in Venous blood

314

2725

0.87

1.75

3.3

3.7

1.8

1.7

mmol/l

1.50

308

2674

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

748

0.74

1.75

1.2

1.4

—

(3023199) Leukocytes [#/volume] in Pleural fluid

176

1603

0.83

1.75

1.4

1.5

3346.2

1992.6

e6/l

0.57

131

1162

(3008116) Ketones [Moles/volume] in Urine by Test strip

156

1.60

1.72

1.2

1.3

—

(3044009) aPTT.lupus sensitive (LA screen)

0.00

1.72

0.0

1.1

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

456

0.68

1.71

1.3

1.4

3.6

2.5

0.33

374

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

482

0.69

1.70

1.1

1.2

105.3

95.2

u/l

0.22

416

(3051387) C reactive protein [Mass/volume] in Capillary blood

307

2006

1.16

1.69

4.1

4.0

35.2

30.5

mg/l

1.19

231

1374

(3020891) Body temperature

567

3855

1.11

1.68

3.5

4.4

—

(3033658) Prothrombin time (PT) actual/Normal

2421

19084

0.95

1.67

3.4

4.0

78.8

80.8

3.02

2332

18628

(3028308) Erythrocytes [#/volume] in Pleural fluid

161

1471

0.82

1.67

1.4

1.5

44528.1

62567.5

e6/l

0.64

875

(3000850) Epithelial cells [#/volume] in Urine

2641

19064

1.06

1.67

2.9

2.8

5.8

5.0

e6/l

2.47

2326

16690

(3003888) Timothy IgE Ab [Units/volume] in Serum

270

0.59

1.67

1.0

1.8

1.5

u/ml

—

106

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

524

0.70

1.66

1.3

1.4

62.2

67.8

0.46

417

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

279

0.59

1.66

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

279

0.59

1.66

1.0

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

192

0.51

1.65

1.5

1.3

27.8

30.5

umol/l

0.91

184

(3006442) Creatine [Moles/volume] in Serum or Plasma

458

0.69

1.60

2.3

1.8

—

71.8

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

102

973

0.79

1.59

1.2

1.3

25.9

12.1

u/l

1.57

888

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

418

3531

0.89

1.58

2.1

2.5

49.1

29.5

au/ml

—

(3030313) Adrenal Ab [Titer] in Serum

2.78

1.58

1.0

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

312

0.63

1.58

1.6

1.5

5.2

6.3

u/l

0.81

251

(1761482) Bacteria [#/volume] in Urine by Culture

374

3180

0.88

1.57

4.9

5.1

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

0.00

1.55

0.0

13.2

—

215.9

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

320

0.64

1.55

2.5

1.8

528.2

479.2

e6/l

0.18

278

(40758358) Immune stain study

0.00

1.54

0.0

1.0

—

(40768446) Kidney Pathology biopsy report

157

0.48

1.54

1.0

1.4

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

167

0.50

1.54

1.2

1.5

137.9

132.0

ng/l

0.06

167

(3022689) Creatine [Moles/volume] in Urine

176

0.51

1.51

1.3

1.4

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

262

0.60

1.51

1.0

0.5

1.3

u/ml

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

156

1.55

1.50

1.0

1.1

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

1159

8184

1.07

1.50

3.2

5.3

1.6

1.4

mmol/l

5.68

1094

7774

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

878

0.79

1.47

1.2

1.4

14.1

13.7

u/l

0.24

836

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3887

30193

0.96

1.46

2.6

3.0

146.1

157.6

ug/l

1.84

3288

26803

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

189

1677

0.85

1.46

1.5

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

118

0.45

1.45

1.0

1.2

—

13.5

—

(3045788) Cell count panel - Pleural fluid

134

1225

0.82

1.44

1.5

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

192

0.55

1.43

1.2

1.3

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

162

1454

0.84

1.43

1.3

1.5

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

146

911

1.21

1.43

2.0

1.6

28.7

26.4

u/ml

0.26

188

(3000034) Microalbumin [Mass/volume] in Urine

782

0.78

1.43

2.3

3.0

37.8

33.3

mg/l

0.14

595

(3021901) Oxygen saturation in Capillary blood

241

2093

0.87

1.42

2.4

2.9

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

756

0.78

1.42

1.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

106

0.43

1.42

1.2

1.0

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

542

0.74

1.42

1.1

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

0.41

1.40

1.0

1.6

—

(3026782) Osmolality of Urine

2532

18344

1.05

1.39

3.0

564.8

539.9

mosm/kgh2o

8.37

2116

15556

(3015235) Bicarbonate [Moles/volume] in Capillary blood

320

2722

0.88

1.39

2.6

3.1

25.0

mmol/l

0.05

290

2378

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

320

0.66

1.39

1.1

1.2

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

0.40

1.39

9.2

7.8

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

811

0.79

1.37

1.2

1.4

146186.5

194438.4

e6/l

0.23

560

(3003396) Base excess in Arterial blood by calculation

1558

11148

1.06

1.37

3.9

5.7

1.3

1.2

mmol/l

0.62

1148

8506

(3047007) Chlamydophila sp Ab [Presence] in Serum

486

0.73

1.36

1.4

1.2

—

(3044927) Protein electrophoresis panel - Urine

128

1167

0.82

1.36

1.3

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

555

0.75

1.36

3.1

2.7

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

318

0.66

1.36

1.1

1.2

—

(3025577) Chromium [Mass/volume] in Blood

623

0.76

1.35

1.8

1.9

1.6

2.2

ug/l

1.09

521

(40765089) Chromosome analysis panel - Blood by G-banded

2.66

1.35

1.2

1.0

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

137

1.54

1.32

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

224

0.61

1.31

1.1

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

465

0.73

1.31

1.1

1.2

34.5

29.5

u/l

0.24

394

(3003129) Base excess in Capillary blood by calculation

233

0.61

1.31

1.5

1.9

1.2

0.8

mmol/l

0.16

216

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

101

0.45

1.30

1.0

—

(4034850)

349

2352

1.12

1.28

12.9

13.9

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.82

1.28

1.1

1.0

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

214

1856

0.87

1.27

1.3

1.4

—

(3006462) Nitrate [Presence] in Urine

419

0.72

1.27

4.9

4.3

—

(3034426) Prothrombin time (PT)

123

0.49

1.26

1.0

1.2

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

539

0.75

1.26

1.2

1.5

—

(3014891) Appearance of Pleural fluid

220

1.41

1.25

1.4

1.5

—

(3011648) Oxygen content in Venous blood

547

0.76

1.25

1.2

1.5

9.6

10.2

0.35

547

(3020393) Adenovirus Ag [Presence] in Stool

1.73

1.25

1.1

1.0

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

538

0.76

1.24

1.2

1.5

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

246

0.64

1.20

1.6

1.7

5261.5

19767.0

e6/l

1.04

142

(3016038) Potassium [Moles/volume] in Urine

108

668

1.22

1.20

1.1

36.9

34.4

mmol/l

0.53

554

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

130

0.52

1.20

1.0

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

141

1.50

1.19

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

272

0.66

1.18

1.6

1.9

615.4

6023.3

e6/l

0.96

189

(3022229) Phosphate [Moles/volume] in Urine

0.00

1.18

0.0

1.1

—

16.0

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

151

0.55

1.17

7.0

8.2

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

724

5855

0.93

1.17

4.1

6.9

1.5

1.3

5.84

717

5802

(40758558) Short blood count panel - Blood

2328

18192

0.96

1.15

5.0

6.3

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.79

1.14

1.1

1.0

—

(3011288) Drugs identified in Urine by Screen method

1.60

1.13

1.4

1.8

—

(3028433) Virus identified in Specimen by Culture

224

0.64

1.13

1.2

1.1

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

722

5830

0.93

1.13

4.1

7.0

0.7

4.04

713

5777

(3036670) Protein [Mass/volume] in Synovial fluid

313

0.70

1.12

1.1

1.2

40.7

40.2

g/l

0.09

153

(3027008) Opiates [Presence] in Urine

143

1.48

1.12

1.1

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

624

4363

1.08

1.12

2.4

3.6

24.1

mmol/l

0.19

561

3884

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.82

1.11

1.0

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.82

1.11

1.0

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.82

1.11

1.0

1.1

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

595

4834

0.92

1.10

5.0

7.8

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

138

0.55

1.10

4.3

1.6

231.4

219.4

—

124

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

138

0.55

1.10

1.1

—

(3028300) Cannabinoids [Presence] in Urine

144

1.47

1.09

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

166

0.59

1.08

1.3

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

534

0.78

1.08

1.1

—

(3008295) Osmolality of Serum or Plasma

129

823

1.18

1.07

1.3

277.0

274.4

mosm/kgh2o

0.48

579

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

232

1972

0.88

1.07

1.3

1.4

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

274

0.69

1.06

1.1

1.3

5.4

13.8

umol/l

2.29

181

(3016879) Cocaine [Presence] in Urine

139

1.46

1.05

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

459

3179

1.09

1.04

3.6

3.3

0.8

nmol/l

0.81

351

2471

(3035880) pH of Pleural fluid

731

0.81

1.04

1.1

1.3

—

(3045716) Anion gap in Serum or Plasma

437

0.76

1.03

1.5

1.9

8.8

9.1

mmol/l

0.19

337

(3014148) Varicella zoster virus Ab [Titer] in Serum

281

0.70

1.03

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

0.47

1.03

1.4

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

218

0.66

1.02

5.3

5.7

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

159

1.42

1.02

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

190

0.63

1.01

1.3

55.7

39.5

u/l

—

150

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

561

0.79

1.00

1.1

1.2

1.0

1.5

nmol/l

4.21

503

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

0.99

0.0

2.2

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

122

0.56

0.99

1.1

1.2

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.00

0.96

0.0

2.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

0.96

0.0

1.4

—

313.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

132

0.57

0.96

1.1

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

0.51

0.96

2.8

1.4

69.0

48.7

pmol/l

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1235

8885

1.05

0.95

4.1

6.3

119.8

118.4

g/l

1.56

1185

8558

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

634

5100

0.93

3.7

5.8

24.7

24.8

mmol/l

0.31

623

5028

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

188

1.36

0.93

1.1

1.0

1.2

u/l

2.69

101

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

318

0.73

0.93

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.48

0.90

1.0

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

164

1.38

0.89

1.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

147

0.61

0.88

2.9

2.5

—

(3044242) Glucose [Moles/volume] in Arterial blood

527

1.20

0.88

1.8

1.7

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

183

0.66

0.88

1.1

—

(3015183) Erythrocyte sedimentation rate

128

0.59

0.87

1.0

1.4

—

(4211845)

450

0.79

0.87

4.7

4.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

482

0.80

0.85

1.1

1.2

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1536

11144

1.04

0.85

3.9

5.7

4.9

5.0

kpa

5.11

1436

10476

(3027801) Oxygen [Partial pressure] in Arterial blood

1535

11137

1.04

0.85

3.9

5.7

11.2

11.6

kpa

2.59

1434

10463

(3000570) Elastase.pancreatic [Mass/mass] in Stool

275

2278

0.91

0.85

1.3

1.4

259.4

261.3

ug/g

0.05

137

1418

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

372

0.77

0.85

1.0

1.1

2.5

12.3

nmol/l

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

208

0.69

0.84

1.4

1.5

0.4

ug/l

—

108

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.52

0.84

1.0

2.3

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

216

0.70

0.83

1.8

1.6

132.3

114.5

ug/l

0.21

182

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

151

1292

0.88

0.83

2.0

2.2

35.5

29.3

mg/l

0.48

306

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

438

0.79

0.83

1.3

1.4

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

153

0.64

0.82

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

518

1.19

0.81

2.5

2.1

1.5

2.4

u/field

1.01

337

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

167

1.35

0.81

1.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.81

0.0

5.0

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

155

1320

0.88

0.80

1.5

3.1

4.3

iu/l

1.38

365

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

524

4213

0.93

0.79

2.0

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

978

7714

0.95

0.77

3.3

3.8

1.2

mmol/l

0.24

754

6668

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

229

0.72

0.76

1.5

1.9

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1.70

0.75

2.0

1.4

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

122

0.62

0.75

1.1

1.2

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

114

748

1.15

0.74

1.3

275.0

326.7

titre

0.15

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

143

954

1.13

0.73

2.5

2.4

2.3

u/field

0.10

303

(3023323) Follitropin [Units/volume] in Serum or Plasma

304

0.77

0.73

1.4

63.7

35.2

iu/l

3.28

256

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

764

0.86

0.72

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.53

0.71

1.0

1.1

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

129

0.64

0.70

1.1

1.2

15.4

17.5

u/l

—

(3010421) pH of Blood

362

2537

1.08

0.70

3.6

4.3

7.4

0.77

299

2163

(3027944) Amphetamines [Presence] in Urine

140

1.35

0.68

1.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

0.52

0.67

1.0

1.1

—

0.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

215

0.74

0.67

1.3

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.65

0.67

1.4

1.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

180

0.71

0.67

1.6

1.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

127

0.65

0.66

1.0

—

(3022621) pH of Urine by Test strip

771

5545

1.05

0.66

4.2

3.7

—

(1616796) Gas panel - Central venous blood

283

2307

0.92

0.66

3.2

3.8

—

(3016502) Oxygen saturation in Arterial blood

1367

9959

1.04

0.66

4.0

5.9

94.8

95.1

0.80

1306

9521

(3002619) Bacteria identified in Specimen by Culture

179

0.72

0.65

1.3

1.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

179

0.72

0.65

1.4

0.1

nmol/l

—

129

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

179

0.72

0.65

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

117

0.64

1.2

1.1

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

9236

70113

0.98

0.63

22.6

23.4

87.3

88.0

umol/l

0.85

9230

70065

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

175

1.29

0.63

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

528

0.84

0.63

1.7

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

584

0.85

0.62

1.0

1.1

—

19.8

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

160

0.71

0.62

1.3

1.1

222.2

255.8

pmol/l

—

105

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

489

3899

0.94

0.62

1.9

1.8

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

0.61

0.0

7.1

—

42.2

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.61

0.0

13.9

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.00

0.61

0.0

1.1

—

0.0

—

(36303858) Crystals [Presence] in Urine

0.00

0.61

0.0

1.2

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

0.61

0.0

7.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.61

0.0

1.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

109

726

1.13

0.60

1.3

51.4

57.4

titre

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.60

0.0

1.2

—

(3044941) Cell count panel - Synovial fluid

157

1307

0.90

0.60

1.4

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

167

0.72

0.59

1.1

0.6

0.7

umol/24h

—

(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid

0.00

0.59

0.0

3.6

—

17.2

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.59

0.0

1.1

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

158

0.72

0.59

1.1

—

9.3

—

(3000012) Reticulocyte production index

644

0.87

0.58

1.7

1.5

—

(40757494) Bilirubin.total [Moles/volume] in Blood

490

0.85

0.58

1.7

2.0

20.3

25.1

umol/l

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

954

7456

0.96

0.55

1.6

1.9

0.2

g/l

0.07

806

6793

(3037756) Immunofixation for Serum or Plasma

291

2348

0.93

0.55

1.3

1.5

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

607

4366

1.05

0.55

1.8

3.2

2.3

ug/l

0.50

452

3720

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

1.62

0.55

1.0

1.1

—

4.0

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

139

1.30

0.55

1.1

1.3

75.8

103.6

ug/l

0.55

(3002032) Base excess in Venous blood by calculation

1291

9442

1.03

0.53

2.6

3.5

2.0

mmol/l

0.31

1045

7571

(3020961) Endomysium IgA Ab [Titer] in Serum

268

2159

0.93

0.50

1.1

465.6

221.6

titre

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

144

0.73

0.49

1.5

1.4

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

375

0.84

0.48

1.1

2.5

65.5

67.7

mg/l

0.09

242

(3006184) Hemoglobin [Mass/volume] in Capillary blood

291

2331

0.94

0.47

2.2

2.3

127.0

124.6

g/l

1.01

240

1733

(3003181) Sodium [Moles/volume] in Urine

268

1894

1.07

0.47

1.3

62.1

60.7

mmol/l

0.27

215

1518

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

117

0.71

0.47

1.0

1.1

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

699

5070

1.04

0.47

3.5

2.9

0.5

0.3

e6/l

1.01

684

4982

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1073

8334

0.97

0.47

2.1

2.5

10.8

9.9

umol/l

0.44

853

7207

(3029634) Reagin Ab [Titer] in Serum by VDRL

463

0.86

0.47

1.4

—

3.8

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

170

1.24

0.47

1.1

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

7579

57555

0.98

0.47

5.4

7.4

83.2

83.4

u/l

0.07

6772

53568

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

567

0.88

0.46

1.1

1.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.40

0.46

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

0.60

0.46

1.2

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1290

9463

1.03

0.46

2.6

3.5

5.9

5.8

kpa

1.21

1225

9143

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.43

0.46

1.0

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

107

0.70

0.45

1.0

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

708

0.89

0.45

1.5

1.4

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.32

0.44

3.4

5.4

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

331

0.84

0.44

6.0

5.7

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

132

0.74

0.43

1.8

1.6

9.6

ug/l

0.00

132

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

132

0.74

0.43

1.0

1.3

113.5

113.6

—

115

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

132

0.74

0.43

1.0

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.47

0.43

1.0

1.1

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2028

14984

1.02

0.43

3.0

3.1

1.7

1.5

e6/l

0.45

1151

8888

(3027945) Reticulocytes/100 erythrocytes in Blood

1677

12365

1.03

0.42

2.1

2.2

1.7

1.8

0.48

1297

10690

(3025941) Bacteria identified in Stool by Culture

498

3598

1.04

0.42

1.3

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

125

1.27

0.42

6.5

8.8

13.6

13.8

0.52

125

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.42

0.0

1.0

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.42

0.0

1.0

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.41

0.0

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.41

0.0

1.2

—

8.3

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.41

0.0

4.6

—

365.2

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

385

0.86

0.41

1.3

575.7

263.5

ug/l

0.26

207

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.37

0.41

1.0

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

214

0.81

0.41

1.0

1.2

1.4

mmol/l

0.03

128

(3051611) Lipemic interference index of Serum or Plasma

122

1002

0.92

0.41

3.2

3.4

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

197

0.80

0.40

1.3

2.9

1229.2

u/l

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.40

0.0

1.1

—

36.1

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.1

—

(3052851) Hemolysis interference index of Serum or Plasma

357

2824

0.95

0.40

3.3

3.7

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.68

0.40

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

0.66

0.40

1.3

1.5

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

188

0.80

0.39

1.1

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

163

0.79

0.39

1.1

1.3

80.1

75.1

0.25

138

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

286

0.84

0.39

1.1

—

(3002385) Erythrocyte distribution width [Ratio]

6885

52262

0.99

0.37

24.9

23.9

14.1

0.28

6638

50898

(3012501) Base excess in Blood by calculation

311

2232

1.05

0.36

3.8

4.4

2.7

2.8

mmol/l

0.49

216

1536

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1866

13810

1.02

0.36

1.6

1.9

29.7

30.3

2.53

1783

13380

(3025315) Body weight

0.63

0.36

7.0

5.4

—

(3013290) Carbon dioxide [Partial pressure] in Blood

311

2234

1.05

0.36

3.8

4.5

5.0

kpa

0.01

299

2161

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

670

4892

1.03

0.35

3.3

4.3

46.0

45.9

0.05

660

4834

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

427

0.88

0.35

4.7

86.4

141.7

u/ml

—

124

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

185

0.81

0.35

1.4

1.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

152

0.79

0.35

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

247

1.16

0.35

1.1

—

(3020491) Glucose [Moles/volume] in Blood

561

0.90

0.35

2.0

2.4

7.2

7.3

mmol/l

0.18

380

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

241

1.16

0.33

1.6

1.8

11.2

14.0

nmol/l

1.75

217

(3044007) Cell count panel - Peritoneal fluid

216

0.84

0.33

2.0

1.8

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

416

0.89

0.33

1.8

2.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

334

1.13

0.33

1.0

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

462

0.90

0.31

3.9

3.0

—

(37021550) Renin [Units/volume] in Plasma --upright

141

0.80

0.31

1.3

42.6

77.4

mu/l

—

(3024869) Neuronal Ab [Presence] in Serum

149

0.81

0.31

1.1

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

206

0.84

0.31

1.4

13.0

15.2

g/l

0.53

163

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

124

0.79

0.30

1.2

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

140

0.81

0.30

1.1

1.0

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.26

0.29

1.0

—

(3030467) Casts [#/volume] in Urine by Automated count

3262

24318

1.01

0.29

3.5

0.6

0.5

e6/l

1.13

2556

18842

(3027923) C peptide [Moles/volume] in Serum or Plasma

349

0.89

0.29

1.1

1.3

1.1

1.2

nmol/l

0.07

260

(3027315) Oxygen [Partial pressure] in Blood

310

2243

1.04

0.29

3.8

4.5

7.8

8.2

kpa

6.53

297

2170

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

188

0.84

0.28

1.1

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

212

0.85

0.28

2.6

2.2

—

31.3

—

(40761536) Microorganisms panel - Urine sediment

840

6478

0.98

0.28

4.8

4.7

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

924

6813

1.02

0.28

2.2

2.3

32.0

37.2

u/l

2.53

747

5751

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

0.75

0.27

1.0

1.3

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

799

5882

1.03

0.27

1.7

2.0

409.1

386.3

nmol/l

2.43

663

5274

(3033705) Calcium.ionized [Moles/volume] in Venous blood

210

1659

0.95

0.27

2.6

—

(40762814) Titanium [Mass/volume] in Blood

170

0.84

0.26

2.1

2.0

2.8

3.3

ug/l

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

178

0.85

0.26

1.3

26.5

60.4

g/l

0.56

146

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

486

0.91

0.25

1.2

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

486

0.91

0.25

1.2

1.4

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

129

917

1.06

0.25

2.7

2.9

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.26

0.24

1.2

1.1

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

296

0.89

0.24

1.2

1.4

20.2

21.2

0.08

240

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

121

1.18

0.24

1.3

1.1

1565.7

1773.4

miu/ml

0.29

121

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

958

7356

0.98

0.23

2.7

3.4

90.9

99.5

ng/l

2.09

735

6027

(3026389) Candida sp identified in Specimen by Organism specific culture

126

1001

0.95

0.22

1.3

1.4

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

0.22

0.0

1.3

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.22

0.0

3.6

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

0.00

0.22

0.0

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.6

—

1.9

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.9

—

2.3

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

0.00

0.21

0.0

1.1

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

577

4250

1.02

0.21

3.9

4.4

1.7

1.5

1.51

544

4006

(3029396) Erythrocyte agglutination [Presence] in Blood

1.18

0.21

1.6

1.3

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

0.00

0.21

0.0

1.1

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.3

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

166

0.86

0.21

1.1

1.0

—

(3041096) Erythrocytes [Presence] in Urine by Automated

2504

18691

1.01

0.20

4.5

4.4

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

229

0.89

0.20

3.1

2.5

7.1

7.4

mmol/l

0.35

155

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.20

0.0

1.1

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.20

0.0

1.1

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.20

0.0

1.0

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.20

0.0

3.0

—

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

0.00

0.20

0.0

8.5

—

55.6

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

0.00

0.20

0.0

1.1

—

0.2

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

209

1.12

0.20

1.3

1.5

18.1

16.7

pmol/l

0.70

159

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

149

0.86

0.19

1.1

1.2

36.7

288.8

u/l

—

(3024928) Oxygen saturation in Venous blood

249

1815

1.03

0.19

1.6

2.5

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.16

0.19

1.0

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

116

0.84

0.18

1.5

1.6

45.8

47.6

umol/l

0.09

116

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

124

892

1.05

0.18

1.4

1.6

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

1.24

0.18

1.0

1.1

0.8

1.1

u/field

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.22

0.18

10.9

14.8

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.15

0.17

1.0

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.71

0.17

4.2

4.0

—

(3019977) pH of Arterial blood

629

1.05

0.17

2.1

2.3

7.4

0.92

240

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.18

0.17

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

241

0.91

0.16

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

124

974

0.96

0.16

1.3

1.5

—

(44786800) Granulocytes/100 leukocytes in Body fluid

184

1.11

0.15

1.3

1.4

20.8

21.8

0.05

141

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

184

1.11

0.15

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

325

0.93

0.15

2.3

2.9

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

623

4620

1.02

0.15

2.1

2.5

0.7

1.53

602

4443

(3027273) Bicarbonate [Moles/volume] in Venous blood

696

5324

0.98

0.14

2.8

3.4

25.4

25.1

mmol/l

1.39

663

5175

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.20

0.14

1.2

11.5

12.7

u/l

—

(3016330) Potassium [Moles/time] in 24 hour Urine

0.81

0.14

1.6

1.2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

0.81

0.14

1.6

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

0.85

0.14

1.2

1.1

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

800

6109

0.99

0.14

2.6

3.2

127.1

125.2

g/l

1.93

780

5959

(3023383) Lactate [Moles/volume] in Pleural fluid

393

0.94

0.13

1.2

1.3

4.3

3.4

mmol/l

0.85

358

(40767503) Oxygen content in Capillary blood by calculation

279

2152

0.98

0.13

2.4

2.6

16.1

15.5

1.38

115

1157

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

253

0.92

0.13

1.2

1.1

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

567

4209

1.02

0.13

3.8

4.4

0.9

4.26

535

3960

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

146

1135

0.97

0.12

4.9

5.8

12.9

12.8

mg/l

0.16

122

1015

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.18

0.12

1.0

1.1

—

(4212803)

100

1.13

0.12

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

246

1.07

0.11

1.0

1.1

—

(3006576) Bicarbonate [Moles/volume] in Blood

321

0.94

0.11

3.6

6.3

24.5

24.7

mmol/l

0.12

291

(3032773) Endomysium IgG Ab [Titer] in Serum

423

1.05

0.11

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.11

0.10

1.4

1.7

22.0

15.9

umol/l

—

(3033799) Differential panel - Peritoneal fluid

249

0.94

0.09

1.6

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.05

0.09

1.0

—

(44806071)

1.10

0.09

1.3

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.10

0.09

1.0

1.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

109

0.90

0.08

1.3

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.03

0.08

1.2

1.1

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

0.78

0.08

1.0

1.2

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

280

1.05

0.07

1.3

1.4

77.0

62.5

3.19

241

(3035933) Granulocytes/100 leukocytes in Blood

1.08

0.07

1.6

1.3

—

(3025549) Creatine [Moles/time] in 24 hour Urine

1.12

0.07

1.3

1.4

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.03

0.07

1.4

1.0

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.03

0.07

1.8

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

170

1.06

0.06

1.1

1.2

118.8

135.9

nmol/l

0.23

125

(3051651) Icteric interference index of Serum or Plasma

527

1.03

0.06

3.2

3.5

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.90

0.06

1.7

1.6

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

154

1181

0.98

0.06

1.3

1.4

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

349

1.04

0.06

1.2

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

527

0.97

0.06

2.1

1.8

291.2

327.4

mu/l

0.37

484

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

103

793

0.98

0.06

1.3

1.5

—

(3001729) Color of Synovial fluid

0.91

0.05

1.8

1.7

—

(44790047)

762

0.98

0.05

1.4

1.3

—

(44790048)

762

0.98

0.05

1.4

1.3

—

(44790049)

762

0.98

0.05

1.4

1.3

—

(44806118)

761

0.98

0.05

1.4

1.3

—

(3024263) Appearance of Synovial fluid

457

0.97

0.05

1.4

1.6

—

(3007853) Bacteria identified in Skin by Aerobe culture

1246

9428

1.00

0.04

1.7

1.9

—

(3000285) Sodium [Moles/volume] in Blood

150

1.06

0.04

1.4

1.2

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

3269

24608

1.00

0.02

2.2

2.5

58.7

60.1

u/l

0.59

2919

22496

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

448

3362

1.00

0.02

2.7

3.0

4.3

pmol/l

0.02

363

2848

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

206

1.02

0.01

1.2

1.3

22.9

28.4

0.39

138

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

104

1.01

0.00

1.2

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.00

0.00

1.2

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

448

1.01

0.00

1.1

1.2

228.7

179.6

miu/ml

—

(3003740) Influenza virus B Ag [Presence] in Specimen

241

1.00

0.00

1.0

1.1

—

(3017704) Immunofixation for Urine

591

0.99

0.00

1.3

—

(3002523) Influenza virus A Ag [Presence] in Specimen

237

1.02

0.00

1.0

1.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

154

0.98

0.00

1.1

1.2

0.9

1.9

mmol/l

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

117

1.03

0.00

1.4

1.8

1.4

1.3

ug/l

0.06

108

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

100

0.98

0.00

1.3

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.90

0.00

1.2

1.1

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

0.90

0.00

1.2

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

0.98

0.00

1.0

1.1

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3042517) Benzodiazepines panel - Urine

0.00

0.0

1.0

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.00

0.00

1.2

—

(3017509) Phencyclidine [Presence] in Urine

0.00

0.0

1.0

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.97

0.00

1.0

1.1

1.8

1.7

umol/24h

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.0

1.4

—

1.8

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

3.4

—

3.1

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.2

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

0.0

1.0

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

0.98

0.00

1.0

1.1

—

(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count

0.00

0.0

5.6

—

14.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.90

0.00

1.0

1.1

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

0.00

0.0

1.0

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

0.00

0.0

1.0

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

0.0

1.2

—

3.4

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

0.0

1.0

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

0.00

0.0

1.0

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

0.00

0.0

2.3

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.00

0.0

1.0

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint G6_ALZHEIMER and mortality.

Females

Parameter	HR [95% CI]	p-value
G6_ALZHEIMER	2.419 [2.2, 2.66]	< 0.001
Birth year	0.989 [0.98, 1.0]	0.01

During the follow-up period (1.1.1998 — 31.12.2019), 74328 out of 110920 females with G6_ALZHEIMER died.

Males

Parameter	HR [95% CI]	p-value
G6_ALZHEIMER	2.756 [2.43, 3.13]	< 0.001
Birth year	0.984 [0.98, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 42782 out of 61190 males with G6_ALZHEIMER died.

Mortality risk

Mortality risk for people of age

years, who have G6_ALZHEIMER.

N-year risk	Females	Males
1	0.184%	0.451%
5	1.156%	2.751%
10	2.546%	6.244%
15	4.559%	11.313%
20	8.12%	18.563%

Relationships between endpoints

↥

Index endpoint: G6_ALZHEIMER – Alzheimer disease

GWS hits: 25

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Alzheimer disease

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints